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INTRODUCTION 
“Health is Wealth”, the most precious one for human being is being free from the 
disease. Health is defined as ‘a state of complete physical, mental, social and spiritual 
wellbeing and not merely the absence of disease and infirmity’. In order to maintain the 
health and come out from the disease, we need various type of treatment which includes 
Traditional and Modern systems of medicine. 
 Siddha system of medicine was established by Siddhars. Siddha system is serving 
the mankind to all of its physical, mental and spiritual components of human being. The 
main advantage of Siddha system is to remove the root cause of the disease. They 
classified the diseases on the basis of derangement of three humors Vaatham, Pitham, 
Kabam. Any derangement of the three humours will result in the disease. Food habits 
and life style modifications play an important role in developing the disease by altering 
the three humours. 
Siddhars have stated about four thousand four hundred and fourty eight diseases 
(4448). The disease Karappan is one among them. The symptoms of  Varatchi Karappan 
may be correlated to Eczema in Modern medicine. 
Every substance in the world is said to be formed from Panchabootham. Skin is 
one of the components of the earth. Any deviation in the components of the earth will 
cause disease in the skin.  
There is no cure for eczema, but eczema can be controlled with regular medical 
care and a good treatment plan. Effective eczema management requires a combination of 
prevention and treatment. In addition to preventing eczema flare-ups by minimizing any 
known triggers, treatment is also an important part of eczema management. It is not a 
contagious disease. It is generally not a serious condition, but there is potential for 
complications, such as a secondary bacterial or fungal infection of the eczema rash. Early 
diagnosis and treatment can reduce the risk for complications. 
 Eczematous diseases are very common with an estimated prevalence of 
more than 10% in the general population. According to statistics 15-25% of all 
dermatological patients suffer from eczema.  
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The incidence of this disease is considerably increasing now-a-days which is 
indicated by the increase in the number of patients reporting at Ayothidoss Pandithar 
Hospital. 
 For the age group 6 to 7 years, the prevalence of current eczema ranged from 
0.9% in India to 22.5% in Ecuador, with new data showing high values in Asia and Latin 
America. The prevalence of eczema is on the increase and currently affects 12-15% of all 
school-age children and 2-10% of adults. (Ref:www.jacionline.org/article/S0091-
6749(09)01535-8/abstract) 
 Siddha medicines are very effective in the treatment of dermatological ailments. 
That’s why the author selects the skin disease ‘Varatchi Karappan’ for the Dissertation 
work. Varatchi Karappan is one of the type of  Karappan which was explained in the text 
‘Yugi Vaidhya Chinthamani-800’.It is also mentioned in the text ‘Siddha Maruthuvam 
Sirappu’ Many herbal and herbo-mineral formulations have been indicated for skin 
diseases. Most of them have been proved effective clinically. So the author selects the 
herbal formulations for the dissertation work. 
 Kukkilaathi chooranam (internal) and Karappan Mel PoosuThylam (external) 
have been chosen as study drugs as they are indicated for Karappan in texts.  
Apart from various internal and external medicines, Siddhars have dealt with 
Yogam. It is effective in sleeplessness by relaxing the mind and also the body. 
This study has therefore been designed to evaluate the therapeutic efficacy of 
“Kukkilaathi Chooranam” (Internal medicine), “Karappan Mel PoosuThylam” (External 
medicine) and Yogam in the treatment of Varatchi Karappan. 
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AIM AND OBJECTIVES 
Primary Objective: 
          To evaluate the therapeutic efficacy of “Kukkilaathi chooranam” (Internal 
medicine) and “Karappan Mel Poosu Thylam” (External medicine) for the disease 
Varatchi Karappan (Eczema). 
Secondary Objectives: 
1. To study the effectiveness of Yogam along with trial drugs in reducing the 
symptoms in Varatchi Karappan (Eczema). 
2. To study the effectiveness of Yogam along with medicine in Varatchi Karappan 
patients. 
3. To evaluate the Siddha diagnostic methods such as Envagai thervu, Neerkkuri and 
Neikkuri etc., in Varatchi Karappan patients. 
4. To do a detailed collection of Literatures of trial drugs and the disease “Varatchi 
Karappan” and review the ideas mentioned in ancient Siddha literatures related to 
the disease. 
5. To analyse the trial drug by biochemical methods. 
6. To do toxicological studies by animal studies to ascertain the safety of the trial 
drugs. 
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HABIT 
Consumption of non-vegetarian foods 
Intake of maize, pearl millet, foxtail 
millet, kodo millet, little millet and 
certain tuberous roots. 
 
 
 
Excessive sexual indulgence. 
 
 
fug;ghd;- KARAPPAN 
Neha; ,ay;- DEFINITION 
 Njhypy; jpkpu;> FU> Gz;> jbg;G Mfpa Fwp Fzq;fis cila gilfis 
cz;lhf;fp mt;tplq;fspy; tPf;fk;> nfhg;Gsq;fs; fz;L my;yJ nrjpy; Nghd;W Njhy; 
RuRug;ghfp Njhypd; ,aw;if epwj;ij NtWgLj;jp rpyNtis ntbg;G cz;lhf;fp 
ePu;frpjy; Mfpa FwpFzq;fis fhl;Lk; Njhw;gpzpfis fug;ghd; my;yJ fug;gd; 
vd;W $Wtu;. ,jpy; jpdTk; nrhupTk; ,Uj;jYk;> ,y;yhjpUj;jYk; cz;L. 
It is characterized by itching, papules, vesicles formation, scaling, hardening of 
skin with change in colour sometimes manifesting with cracking of lesion exudating 
watery fluid. 
Neha;f;fhuzk; - AETIOLOGY OF DISEASES 
 
  ‘kpfpDk; FiwapDk; Neha; nra;Ak; E}Nyhu; 
  tspKjyha; naz;zpa %d;W”. 
- jpUts;Stu; 
According to Thiruvalluvar, a disease is produced due to increase or decrease of three 
thodam such as Vaatham, Pitham and Kapham. 
 
 
     AETIOLOGICAL FACTORSACCORDING TO YUGI MUNIVER 
   
 
   
 
 
 
 
 
 
 
 
 
FOOD 
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According To Yugi Vaidhya Chinthamani: 
 ‘Vohd fug;ghdpd; cw;gj;jp Nfsha; 
 Vw;w khkprq;fs; Grpf;if ahYk; 
 $ohd fk;Gjpid tuF rhikf; 
 Nfhbjhd fpoq;F tifaUe; jyhYk; 
Ghohd ngz;khia jd;dpw; rpf;Fk; 
ghq;fhd tpufj;jhd; Kaw;rp ahYk;” 
According To Guru Naadi Nool 
   ‘tay;jdpNy g+ehf kz;izj; jhNd 
    tUe;jpaJ Gj;Jg;Nghy tj;ij ahFk; 
gay; nkhopaPu; Njfj;jpy; fpUkpjhNd 
gue;JUfp Fl;lk; Nghy; Gs;spfhZk; 
kayJTq; fpUkpAe;jhd; ele;JGf;fpy; 
NkdpaJrurnud ntbj;Jg; Gz;zhk; 
fay;ngUFk; Foy;kltPu; nrhy;yf; Nfspu; 
    fufuj;Jr; nrhwpngUFq; fughd; jhNd”  
   ‘rq;ifapy; tp\fug;ghd; tUkhNwJ 
    rhuKld; fpUkptpOe; jd;ikNaJ” 
   cl;bzNk mjpfk;tU kpe;jpupa Nghfj;jh 
    YDUfp aj;jpNy NtT nfhz;L 
   el;lzkha; nte;jnjhU kr;ir jd;dpy; 
    ehl;lkpl;Nl fpUkpaJ aZFk; NghJ 
   kl;LlNd fpUk pnay;yhk; gwe;jq;Nfwp 
    tifAlNd khq;fp\j;ijj; Jisj;J NkTk; 
   jpl;lKld; tplfug;ghd; gwe;JNkNy 
    jpdTlNd guguj;Jr; nrhwp Az;lhNk” 
                   -   FUehb E}y; 
Relevance of Guru Naadi Nool: 
· Karappan occurs due to infestation with parasites and worms and it is 
symptomised by itching, cracking and ulceration of skin. 
· Vida Karappan is a type of Karappan and is produced due to destruction of 
vital organs of the body by the infection, excessive sexual indulgence which 
is symptomised by intensive itching. 
6 
 
In the text “Vaithya Chintamani Karappan Roga Nidhanam” 
Karappan is produced due to: 
· Consumption of offending food substances. 
· Sexual indulgence with elderly women. 
· Cutting of fruit bearing trees. 
· Psychosomatic factors. 
   ‘thj gpj;jq; fgkpit %d;Wte; 
    NjJtha; ntapyhd; kbahypfw; 
   Nfhijahu; kayhu ;ntau; thw;Fspu; 
    NgjePupit khYsNgR Nfspd; 
   Ntjf; fhw;wpjp ew;gid nty;yj;jhy; 
    ghfkpd;fs; thd;Nkjpg; ghnda;apy; 
   jhfkhypd; tLf;fdp rhu;jyhy; 
    Nkhfthio tOjiy Ks;spf;fha; 
   fhAk; gy;yplj; jhw;Ruj; jhw;fdy; 
    VAk; td;nlyp ahy;tU NkJntd; 
   UA ey;ywp thd uUspdhu; 
    kha khd fug;ghd; tiffNs” 
- guuhr Nrfu fpue;jp epjhdk; 
According to Pararaasa Sekara Kirandhi Nidhanam: 
· Drinking of contaminated water. 
· Eating of banana , cucumber, brinjal, fish. 
· Poisons of rats. 
Food items inducing Karappan as mentioned in Siddha literature are”- 
  ‘ngUFQ; NrhskpWq;Fk; ngUk;fk;G 
  tuFfhUld; thioapd; fhnahL 
  ciunfhs; ghfw; nfspw;WkPd; cz;bby; 
  tpuptjhaf; fug;ghDkpFe;jNj” 
- rpj;jkUj;Jtk; rpwg;G 
Nrhsk; Maize 
  ‘Nrhsnkdg; Ngu;gilj;jNrhWfspdhYlypy; 
  kPsr; nrhwprpuq;Ftpu;j;jpjhk; - ehSq; 
  fug;ghDk; cz;lhk; fdkUe;Jk; ghohk; 
  gug;guidafzkhdNj!ghu;” 
- mfj;jpau; Fzthflk; 
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fk;G - Pearl millet 
 ‘fk;GFspu;r;rp nadfhrpdpapw; nrhy;Ytu; fhz; 
 gk;Gnrhwp rpuq;ifg; ghypf;Fk; - ntk;Gk;” 
- mfj;jpau; Fzthflk; 
tuF - Kodo millet 
 ‘vwpfg NjhNlgy Nehnaa;Jk; twl;rp 
 nrhwprpuq;F gpj;je; njhlUk; - epiwAq; 
 fufnkdg; g+upj;jfr;R KiykhNj! 
 tufupr; Nrhw;why; tOj;J” 
- mfj;jpau; Fzthflk; 
Consumption of maize, pearl millet, kodo millet, unripened banana, bitter guard 
will lead to Karappan disease. 
CLASSIFICATION: 
As per ‘Yugi Vaidhya Chindamani - 800’ the types of  Karappan are seven: 
1. Vatha karappan 
2. Kanda karappan 
3. Varatchi karappan 
4. Thimirvatha karappan 
5. Kabala karappan 
6. Azhal karappan 
7. Iyya karappan.  
In “Pathinen Siddhar Balavagada Thirattu”, Karappan is classified into18 types: 
1. Vali karappan,  
2. Azhal karappan,  
3. Iyya karappan,  
4. Ari karappan,  
5. Oothu karappan,  
6. Soolai karappan,  
7. Vedi karappan,  
8. Mandai karappan,  
9. Pori karappan,  
10. Sattai karappan,  
11. Odukarappan,  
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12. Karun karappan,  
13. Sen karappan,  
14. Kolli karappan,  
15. Thoda karappan,  
16. Vaalai karappan,  
17. Varal karappan,  
18. Veengku karappan.  
In the text ‘AthmaRakshamirtham’ the classification of Karappan is of 20 types: 
1. Vali karappan, 
2. Azhal karappan, 
3. Iyya karappan, 
4. Karun karappan, 
5. Sen karappan, 
6. Mandai karappan, 
7. Ari karappan, 
8. Pori karappan, 
9. Kiranthisoolai karappan, 
10. Vaalai karappan, 
11. Othu karappan, 
12. Sevvappu karappan, 
13. Kolli karappan, 
14. Kadi karappan, 
15. Veengu karappan, 
16. Uthir karappan, 
17. Sattai karappan, 
18. Vedi karappan, 
19. Singamuga karappan, 
20. Eri karappan 
CLINICAL FEATURES OF KARAPPAN  
  ‘vz;gJfug;ghd; jd;idapak;gpLkhWNfspu; 
ez;gpLk; thjk; gpj;jk; eyq;nfl;Lj; jhdk; tPq;Fk; 
 Gz;gLq; fuq;fs; re;JGiye;Jly; fLj;JNehFk; 
td;Gld; ntbj;Jr; #iytUtJuzkPnjd;Nd” 
 
9 
 
‘cisQ;R Nkyapjvd; rPjq; fhZk; 
  c\;zkha; %j;jpue; jhYUq;fp tpOk; 
misQ;R Nkaq;f nky;yhQ; nrhupAz;lhFk; 
moyhf ntJk;gyhf; iffh NyhAk; 
GisQ;R Nkypq;fj;jpw; Ad;Nghyp Uj;jpg; 
nghbnghbaha; Rz;zhk;Gf;fw; Nghy;tpOk;” 
- mfj;jpau; ,uz E}y; 
In Yugi Vaithiya Chinthamani: 
 Varatchi Karappan is symptomised by swelling of face, discrete itching all over 
body, excessive fatigue, debrided wounds with foul smell. 
‘fz;lkha; KftPq;Fq; Fw;wYz;lhk; 
 Fdkhf clk;ngq;F kpfNt CWk; 
Fz;lkhA lk;gijj;Jr; nrhupj;j Yz;lhk; 
 NrhUNk nae;Neu kaf;f j;jhNy 
tz;l fe;jhdp y;yhk Ylk;gh 
 ghlha; g;gfw;wp kWFk; thu;j;ij 
gpz;lkha;f; fple;JUz;L GyhNy ehWk; 
 ngUtwl;rpf; fug;ghdp d;wd; NgupjhNk” 
- a+fpitj;jparpe;jhkzp 
According to Agathiar Rana Nool - Facts about Karappan: 
· Classified into 80 types 
· Produced due to derangement of Uyirthathu, Vaatham, Pitham and Kapham 
· Symptomised by  
Ø Itching 
Ø Cracking 
Ø Oozing 
Ø Pus exudation 
Ø Sloughing 
Ø Oliguria 
Ø Fatigue 
TEXTUAL REFERENCES - VARATCHI KARAPPAN                
In Agathiyar 2000 
· Distributed in leg, scalp, ear, and nose. 
· Symptomised by itching, vesicles formed due to scratching. 
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 ‘fhypjiyAlk; ngq;Fk; fdf;fNt rpWrpwq;fha; 
 NryJfb Jyj;jpj; jpdTld; nrhwptjhfpf; 
 jhyNt fhJehrp kplWjhd; jhdpy; 
 jhy;jUk; kle;ijkhNj>twl;rpNru; fug;ghdhNk” 
- mfj;jpau; 2000 
In Pathinen Siddhar Balavagada Thirattu 
Varatchi Karappan is characterized by formation of infectious vesicles 
distributed from scalp to foot. 
‘cr;rp KjYs;tq;fhYw;wstp nts;splKk; 
  er;Rr; rpWrpuq;F ed;dpNa - epr;ry; 
  fbe;J tur; rpf;fug;ghd; fhz;” 
-  gjpndz; rpj;ju; ghythflj;jpul;L 
In Aathmaratcha Amirtham Varal Karappan: 
· Distributed from scalp to foot. 
· Symptomised by itching, vesicle formation, loss of sleep. 
Curable and Incurable types of Karappan mentioned in Yugi Vaithiya 
Chinthamani 800 as below: 
‘%u;f;fkhk rhj;jpj;ij nkhopaf; Nfsha; 
 Nkhopfpd;wthj fug;ghd;wd;NdhL 
Cu;f;fkhk; gpj;jfug;ghD khFk; 
 cau;fpd;wtul;rpahq; fghyf;fug;ghd; 
jhu;f;fkhkpJehYQ;rhj;jpakhFk; 
 jSf;fhdjpkpu;thjf; fug;ghd;fz;lk; 
jPu;f;fkhQ; Nrl;gfug;ghd;wd;NdhL 
 nrt;tpaNjhupJ %d;Wkrhj;jpahNk” 
Curable types of Karappan are:  
1. Vatha karappan 
2. Pitha karappan 
3. Varatchi karappan 
4. Kabala karappan 
Incurable types of Karappan are: 
1. Kanda karappan 
2. Thimirvatha karappan 
3. Iyya karappan 
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ehbeil: 
1. jhdKs;sNrj;Jke;jhdpsfpy; ....... 
............................ fug;ghd; tpuzNjhlk; 
2. rpwg;ghdthjj;jpy; cl;ze;jhNdNru;e;jpLfpy; 
        .................................. kjfupePu; fug;ghd;  
- FUehb 
NAADI PATTERNS IN KARAPPAN :  
· Kabam 
· Vatham + Ushnam 
DIAGNOSIS OF KARAPPAN 
Diagnosis of Karappan in Siddha system is mainly based on EnvagaiThervu 
(Eight types of examination) and also on other factors like 
· UyirThaathukkal 
· UdalThaathukkal 
· Gnanenthiriyam 
· Kanmenthiriyam 
UYIR THATHUKKAL 
Vaatham 
· In Karappan commonly affected types of Vaatham are Abanan, Viyaanan, 
Samaanan and Devathathan. 
· Derangement of Viyanan leads to itching, dryness of skin, thickness. 
· Involvement of Samanan leads to imbalance of functions of other 
Vaayukkal. 
· Derangement of Devathathan leads to sleeplessness. 
· Derangmentof Abaanan leads to constipation. 
Pitham 
· In Karappan commonly affected type of Pitham is Ullollithee 
(Prasakapitham). 
· Normally Prasakapitham gives complexion to the skin. In Karappan the skin 
becomes hyperpigmented and lose its normal colour. 
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Kabam 
· Kabam is usually not affected in karappan. In my study Santhikam was 
affected in some patients. 
UDAL THAATHUKKAL 
Panchabootham forming the basic constituents of these Thaathukkal get 
deranged. Commonly affected Udal Thaathukkal are Saaram,  Senneer. 
Derangement of Saaram leads to depression and tiredness of mind and body. 
Deranged Senneer affects colour of the skin. 
GNANENTHIRIYAM 
Panchabootham forming the basic constituents of these Gnanenthiriyam get 
deranged. Commonly affected Gnanenthiriyam is Mei producing itching, papule, vesicle 
formation, oozing, crusting, scaling, and hyperpigmentation. 
KANMENTHIRIYAM 
Panchabootham forming the basic constituents of these Kanmenthiriyam which 
are not commonly affected in karappan. 
PINIYARI MURAIMAI (DIAGNOSTIC METHODS) 
Piniyarimuraimai is the method of diagnosing disease. It is based on the 
following principles: 
1. Poriyalarithal 
2. Pulanalarithal 
3. Vinaathal 
 Poriyalarithal and pulanalarithal goes hand in hand with the concept of 
examining the patient’s ‘Pori’ and ‘Pulan’ with that of physician’s ‘Pori’ and ‘Pulan’. 
‘Vinaathal’ is a method of enquiring about the details of the patient’s problem 
from his own words or from his parents or neighbours who are taking care of the 
patient, when the patient is not able to speak (or) if the patient is a child. 
EnvagaiThervu (Eight Types of Examination) 
                  ‘ehbg; guprk; eh epwk; nkhoptpop 
kyk; %j;jpukpit kUj;JtuhAjk;” 
      -  Njud; 
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The Eight Types of Examination 
1. Naadi (Pulse reading)  
2. Sparisam (Tactile sensation)  
3. Naa (Tongue)  
4. Niram (Color)  
5. Mozhi (Speech or Voice)  
6. Vizhi (Eyes)  
7. Malam (Stools)  
8. Moothiram (Urine)  
1.Naadi 
In Karappan the following types of naadi could be felt. They were, 
 Vathapitham 
Pithavatham 
Kabam 
2.Sparisam 
In Karappan patient’s general body temperature  -   slight warmth,  
Dryness, roughness and elevation of skin was noted. 
3.Naa 
In some patients, coated tongue was noted. 
4.Niram 
           Skin colour becomes dark. 
5.Mozhi 
           No change or disturbance in voice was noted. 
6. Vizhi 
          There are no changes in the vision. 
7.Malam 
          In Karappan some patients have constipation. 
8.Moothiram 
Neerkuri 
Urine is collected after taking a well-balanced diet  which do not alter the three 
thodam. It should be examined within 3-3/4 Nazhigai. (90 minutes). 
In Neerkuri, the Niram (Colour), Manam (Odour), Nurai (froth), Eadai (specific 
gravity) and Enjal (deposits) are noted. 
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Apart from these the frequency of urination, abnormal constituents such as 
sugar, protein, presence of  blood, pus, and renal crystals must also be found out. In 
Karappan patients straw coloured urine was noticed. 
Neikkuri: 
The collected specimen as said above is to be analyzed by following method. 
The specimen is kept open in a glass dish or china clay container. It is to be examined 
under direct sunlight, without any shaking of the vessel. Then add one drop of gingelly 
oil on the surface of the urinary specimen and the Neikkuri was noted in direct sunlight, 
and conclude the diagnosis as follows:  
Character of Vathaneer 
“«Ã¦ÅÉ ¿£ñÊÉ·§¾ Å¡¾õ” 
 When the oil drop lengthens like a snake, it is called “VaathaNeer”. 
Character of Pithaneer 
“¬Ç¢ §À¡üÀÃÅ¢ý «·§¾ À¢ò¾õ” 
When the oil drop spreads like a ring, it is called “Pithaneer”. 
Character of Kabaneer 
   “Óò¦¾¡òÐ ¿¢ü¸¢ý ¦Á¡Æ¢Å¦¾ý ¸À§Á” 
 When the oil drop appears like a pearl, it is called “KabaNeer”. 
Character of Thonthaneer 
 Snake in the ring, ring in the snake, snake in the pearl and ring in the pearl are 
the characters of thonthaneer. 
 In Karappan the Neikkuri was Vaathaneer, Pithaneer and Kabaneer. 
NOI KANIPPU VIVAADHAM (DIFFERENTIAL DIAGNOSIS): 
 fhshQ;rf  thjk; 
“khj khq; fhy;ifapy; Fuf;fp uz;Lk; 
 tUj;J re;J KWf;fpNa File;J nehe;J 
ehjkh eiljhDe; jhd;nflhky; 
 eype;JNk Klkhfpf; fuL fl;br; 
NrjkhQ; rle;jhD kpfnt Sj;Jj; 
 jpdNthL rpuq;Fkha;r; Nrl;gkhfpf; 
fhjkha UrpnahL kaf;fkhFk; 
 fUjpa fhshQ; rfkhk; thjkhNk” 
- a+fp itj;jpa rpe;jhkzp 
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KALANJAGA VAATHAM : 
Symptomised by Yugi Vaithya Chinthamani 
· Unrelenting pain in joints 
· Restriction of movements 
· Pallor 
· Syncope 
· Vesicle formation 
glu;jhkiu ngUNeha; 
“$LNkjhkiuapd; g+tpjo;g; Nghy; 
  Ftpe;JNkfWg;NghLntSg;GkhFk; 
NjLNkrptg;Ggytu;zkhFk; 
  jpdTkpfthuhJnrhidapw; gd;dPu; 
thl;LNkma;apZw; gj;jpahfp 
  tUj;jkpfTz;lhfpNehTkhFk; 
NghLNkruPuq;fs; Kfq;fs; fhJ 
  Gz;luPff; Fl;lj;jpd; GJikjhNd” 
- A+fpitj;jparpe;jhkzp 
PADARTHAMARAI PERUNOI – YUGI VAITHYA CHINTHAMANI 
Symptomised by 
· Erythematousness 
· Hypo and Hyperpigmentation 
· Excessive fatigue 
LINE OF TREATMENT 
In Siddha system of medicine, the main aim of the treatment is to cure the 
disease by removing the root cause. Treatment is not only for perfect healing but also 
for prevention and rejuvenation. 
   “§¿¡ö¿¡Ê §¿¡öÓ¾ É¡Ê ÂÐ¾½¢ìÌõ 
  Å¡ö¿¡Ê Å¡öôÀî¦ºÂø” 
   -¾¢ÕÅûÙÅ÷ 
 Thiruvalluvar says in “Thirukkural” about physician’s duty to study the 
disease, study the cause, seek subsiding ways and do what is proper and effective. 
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In Siddha system, the line of treatment consists of: 
· Neekkam (Treatment) 
· Niraivu (Rejuvenation of wellbeing) 
· Kaappu (Prevention) 
Rules for healthy living has been quoted in Patharthagunachinthamani as follows, 
“¾¢ñ½ Á¢ÃñÎû§Ç º¢ì¸ Å¼ì¸¡ÁÈ 
¦Àñ½¢ýÀ¡ ¦Ä¡ý¨Èô ¦ÀÕì¸¡Áø- ¯ñÏí¸¡ø 
¿£÷ÍÕì¸¢ §Á¡÷¦ÀÕì¸¢ ¦¿öÔÕì¸¢ ÔñÀÅ÷¾õ 
§ÀÕ¨Ãì¸¢ü §À¡§Á À¢½¢”.     
     -§¾¨ÃÂ÷ 
Treatment 
· Å¢§ÃºÉõ 
· ¯ûÁÕóÐ 
· ¦ÅÇ¢ÁÕóÐ 
· Àò¾¢Âõ 
Viresanam(Purgation): 
“Å¢§ÃºÉò¾¡ø Å¡¾õ ¾¡Øõ 
ÅÁÉò¾¡ø À¢ò¾õ ¾¡Øõ 
¿º¢Â «ïºÉò¾¡ø ¸Àõ ¾¡Øõ 
Ð¸¢ýÈ ÁÄì¸ð¨¼ ¦Â¡Æ¢Â ¨Åò¾¡ø 
¯¼Ä¢ÖûÇ Å¡¨¾¦ÂÄ¡ ¦Á¡Îí¸¢ô §À¡Ìõ 
«È¢ó¾¢Îõ Å¡¾õ «¼íÌõ ÁÄò¾¢É¢ø”. 
For purgation, Agathiyar kuzhambu with Sangangkuppi juice was administered 
at early morning before starting the treatment to bring the vitiated Uyirthathukkal to 
normal. 
Internal Medicine: 
 Kukkilaathi Chooranam– 1.5gms, two times a day with warm water. 
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Anubanam 
“«ÛÀ¡Éò¾¡¦Ä ÂÅ¢ú¾õ ÀÄ¢ìÌõ 
þÉ¢¾¡É ÍìÌþïº¢ - À¢ÛÓÐ¸¡ø 
§¸¡ÁÂõÀ¡øÓ¨ÄôÀ¡ø §¸¡¦¿ö§¾ý ¦ÅüÈ¢¨Ä¿£÷ 
¬Á¢¨¾Â¡ Ã¡öóÐ ¦ºöÂÄ¡õ” 
- §¾¨ÃÂ÷ ¦ÅñÀ¡ 
External Medicine: 
 Karappan Mel Poosu Thylam 
Pathiyam (Dietary Regimen): 
  “¦ÀÕÌï §º¡Ç Á¢ÚíÌõ ¦ÀÕõ¸õÒ 
ÅÃÌ ¸¡Õ¼ý Å¡¨ÆÂ¢ý-¸¡¦Â¡Î 
¯¨Ã¦¸¡û À¡¸ü ¦¸Ç¢üÚÁ£ý ¯ñÊÊø 
Å¢Ã¢Å ¾¡öì¸Ãô À¡ÛÁ¢Ìó¾§¾” 
- À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
“ÒÇ¢ÐÅ÷ Å¢ïÍ ¸È¢Â¡÷ ÒÃ¢ìÌõ Å¡¾õ” 
- À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
In Siddha system of medicine the importance of dietary habits also emphasised 
for the diseases management and prevention. This line is well understood in the verse, 
given below: In diseased condition diet restrictions or pathiyam are strictly followed to 
increase the effectiveness of medicine for curing diseases. This is given in the following 
verse,  
 Diet restrictions or pathiyam  should be strictly followed in Karappan patients. 
These are prescribed to normalize the deranged thodam and to increase the potency of 
the drugs.  
Patients are strictly advised to follow the dietary and other restrictions: 
· Avoid the maize, pearl millet, kodomillet, fox tail millet, Sesban, Brinjal, 
Kaararisi, Bitter gourd, Pickles, Tamarind. 
· Avoid all non-vegetarian foods. 
· To avoid substances allergic to the particular individual. 
· To take Thiridhoda samapporulkal (elam, manjal, seeragam, kaayam, chukku, 
venthayam, poondu, milagu). 
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· To take vegetables and green leafy vegetables.To take more germinated grams, 
dates, figs and powder of fenugreek regularly.  
· To use Nalunguma a Siddha herbal preparation which contains Sandanam, 
Vettiver, Vilamichamver, Kichilikizhangu, Karbogi, Paasipayiru, Koraikizhangu 
instead of soap and other detergents for bath. 
SPECIAL TREATMENTS: 
Skin is the reflex of mind and so we should treat not only the physical but also 
treat mind and soul. There by patients are advised to do yoga practice. In Karappan, 
patients are advised to do Pranayamam, Dhyanam and Asanams for speedy cure and 
prevention of recurrences. 
1)Yogasanam (Posture): 
· Padhmasanam 
· Sukaasanam 
· Savasanam (Poornasanthiasanam) - Regular practice of asanam maintains 
both physical and mental health.  
2)Pranayamam (Breathing technique): 
· Nithirai pranayamam 
· Omkara pranayamam - are useful to relieve patients stress and strain. Also it 
increases alertness, memory and maintains a clear mind. 
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YOGAM 
Yogam is a precious art that the Siddhars contributed to the Tamil and the Tamil 
medicine, to the Siddha system of medicine, and to the people of the world at large. 
 Yogam is one of the Kayakalpam methods that preserve physical and mental health 
by preventing the approach of grey hair, wrinkling, disease and death. 
 There are people who think only of Yogasanam (postures) whenever we use the term 
Yogam but Yogam consists of eight steps and hence is called AttangaYogam. 
 The term Yogam means “Union”. Siddhars have defined Yoga as an art which 
controls the mind by preventing it from getting distracted through sense and sense organs and 
by uniting it with the divinity after realizing the truth of eternal bliss. Professor Yogi 
Ramaiah has explained this simply as “A perfect scientific art that unites the mind with God 
or to the Truth”. 
 The eight steps or stages of Yogam are described in a verse of Thirumanthiram, also 
called Tamil Moovayiram. 
“þÂÁ ¿¢ÂÁ§Á ±ñ½¢Ä¡ ¬¾Éõ 
¿ÂÓÚ À¢Ã¡½¡ Â¡ÁõÀ¢Ãò ¾¢Â¡¸¡Ãï 
ºÂÁ¢Ì ¾¡Ã¨½ ¾¢Â¡Éï ºÁ¡¾¢ 
«ÂÓÚõ «ð¼¡í¸ Á¡ÅÐ Á¡§Á” 
 
ü Iyamam 
ü Niyamam 
ü Asanam 
ü Pranayamam 
ü Prathyakaram 
ü Dharanai 
ü Dhyanam 
ü Samathi 
ASANAM 
 Asanam means posture or pose, that is, the position of our body with reference to 
space. There is another interpretation by Siddhars: A + Samanam – A means athma and 
Samanam means poise or relaxation. Relaxing athma implies relaxing it from stressful 
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conditions of this worldly life. In other words, it means relieving athma from the lure of 
sensual pleasures. As Asanam forms a part of Yogam it is also called Yogasanam. 
Definition: 
 Keeping the body or part of the body steady and motionless in a particular posture for 
a specific time is Asanam. 
YOGAM TECHNIQUES TO BE OBSERVED BY THE KARAPPAN PATIENTS 
ü Meditative postures 
o Padmasanam / Sukasanam 
ü Pranayamam 
o Omkara Pranayamam  
o Nithirai Pranayamam 
ü Savasanam 
 MEDITATIVE POSTURES                                                           
      PADMASANAM 
Tamil name: ThamaraiAsanam 
English name: Lotus pose 
The term Padmam or Thamarai means lotus. The beginners in Asanam should get 
trained in this Asanam first, because this form is a basic asanam for many other asanams. 
This asanam is one of the meditative postures. 
Technique: 
 (1).Put the right leg on the left thigh, keeping the right heel pressing down the lower 
abdomen or (2).Put the left leg on the right thigh,keeping the left  heel pressing down the 
lower abdomen. This posture is called Paathi Thamaraiasanam (Ardhapadmasanam - half-
lotus pose) 
 Beginners in Thamaraiasanam better practice half-lotus pose for some days. First day 
they can practice (1) and the subsequent day (2) as explained above, and this can be 
continued alternatively for some days and then lotus pose in its full form can be practiced as 
follows: 
First do as explained in (1) and follow the steps as explained in (2) above. i.e., 
combine (1) and (2). Now place left hand with palm facing upward on the lap and then right 
hand similarly over the left (Pambu or Bairavamuthirai)  or place the hands on the knees, 
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with palms facing upwards and keep the thumbs and the index fingers touching each other in 
the form of a circle and keep the other three fingers extended (Gnana muthirai). 
The vertebral column should be kept erect and head straight with eyes closed or open 
depending upon the meditation technique. This is Puranapadmasanam (complete lotus pose) 
To begin with, this Asanam can be practiced for 1 to 3 minutes and the duration can 
be increased according to our need in the course of time. 
Relaxing the Asanam: 
From the summit or the final completed stage of Asanam, the Asanam should be 
relaxed step by step in the reverse order. First, the left leg followed by the right leg should be 
taken away from the thighs to reach Sukasanam, then stand up and finally to the zero stage. 
The counterpose for this Asanam is Savasanam or Pooranashanthiasanam. 
Benefits: 
· Calms the brain. 
· Mental concentration is increased. 
· Joints, especially the knee joints are strengthened. 
· Prevents joint disorders in old age. 
· Increases digestive function. 
· Produces clarity of the mind and briskness. 
· Stimulates the pelvis, spine, abdomen, and bladder. 
· Eases menstrual discomfort and sciatica. 
· Consistent practice of this pose until late into pregnancy is said to help ease 
childbirth. 
· Traditional texts say that Padmasanam destroys all disease and awakens kundalini.  
· The thigh and calf muscles become stronger. 
· Arthritis of knee, ankle and hip joints is relieved with practice of Padmasanam. 
· The pose helps attain a straight posture. 
· Padmasanam ensures the required blood supply to the abdomino-genital and pelvic 
areas. 
· Padmasanam tones up the abdomen and spine. 
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SAVASANAM 
English Name: corpse pose 
 This posture is so named, in the summit of this posture one observes a motionless 
state (except breathing) like that of dead body. 
Technique: 
 Lie down on the back on a nice bedspread spread out on a floor with an even surface. 
With palms facing upwards on the sides half a foot apart from the body. Leaving half a foot 
gap in between the heels, keep the legs in a relaxed manner. By allowing the head to turn 
freely to left to right side, keep the head and neck in a relaxed manner. Keep the eyes gently 
closed. Maintain normal breathing. Keeping the whole body from head to foot in a relaxed 
manner. Observe this Asanam for 15 to 30 minutes or even more, if necessary. 
 
 
Benefits: 
ü Relieves physical and mental tiredness. 
ü One must do this asanam lastly after performing all other asanams and may maintain 
this till the physical and mental tiredness resulting from performing a number of 
asanam get relieved. 
ü If hard physical labourers do this asanam as soon as they return home from work, it 
improves good refreshment and tiredness would take leave of them. 
ü Sound sleep ensues if one observes this asanam for about 10 minutes before retiring to 
bed. Calms the brain and helps relieve stress and mild depression. 
ü Relaxes the body. 
ü Reduces headache, fatigue, and insomnia. 
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PRANAYAMAM 
The perfect and scientific art of controlling one’s breathing is called Pranayamam. It 
is also called Vaasi or Vaasiyogam. By bringing to control the breathing that goes normally, 
automatically and in a regular rhythm and fixing the duration and amount of breathing 
differently as described by Siddhars, different types of Pranayamam are devised.   
Pranayamam is one of the rejuvenation techniques which prolong one’s lifetime. This 
is indicated by Thirumoolar as follows: 
“²üÈ¢ þÈì¸¢ þÕ¸¡ÖõâÃ¢ìÌõ 
¸¡ü¨È À¢ÊìÌõ ¸½ì¸È¢ -Å¡Ã¢ø¨Ä 
¸¡ü¨È À¢ÊìÌõ ¸½ì¸È¢ Å¡Ç÷ìÌì 
Üü¨È ¯¨¾ìÌõ ÌÈ¢ÂÐ Å¡§Á” 
²üÈ¢ þÈì¸¢ denotes the act of increasing or decreasing the quantity of air inspired 
during respiration. þÕ¸¡ÖõâÃ¢ìÌõ denotes saturating the two lungs with the vital air by 
inspiring through the nostrils. In this ¸¡ü¨ÈÀ¢ÊìÌõ ¸½ì¸È¢ Å¡Ç÷ is the one who is 
engaged in the practice of Pranayamam. ÜüÚ means Yaman, the one who takes the life 
from the body. Üü¨È ¯¨¾ìÌõ ÌÈ¢ means that Pranayamam is the means of preventing 
Yaman from approaching the one who practices it. 
Benefits: 
ü Pranayamam not only useful in the treatment of diseases of lungs and respiratory tract 
but proves beneficial as a main or supportive therapy in the treatment of diseases of 
skin, nervous system including brain, and diseases of the mind. 
ü It is useful in developing body resistance and also in increasing the memory and 
mental concentration. 
ü It removes bad odour and renders sattvika gunam (good characters) predominant. 
NITHIRAI PRANAYAMAM 
English Name: Sleeping Pranayamam. 
Technique:  
1. Sit on a bedspread or a smooth mat in Sukhasanam or Padmasanam with Pambu 
Muthirai (Bairava Muthirai) or Chin Muthirai.  
2. Close your eyes and concentrate on your breathing. 
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3. Through both nostrils breathe in slowly, steadily and gradually to the maximum at the 
same time calculating the total time taken for this Poorakam (inspiration) by counting 
inwardly as 1, 2. 3 ….at the same pace throughout. 
4. As soon as the Poorakam is over, start Resakam (expiration) observing the same 
technique explained in 3 but see to it that the time taken for expiration is only half the 
time taken for inspiration.  
5. Repeat the technique 30 to 40 times. 
N.B: The above description is based on the teachings of Yogi S. A. Ramiah. 
Benefits: 
ü Induces sleep.  
ü Relieves stress and other symptoms like headache, heaviness of head, tiredness.  
OMKARA PRANAYAMAM 
Technique: 
1. Sit on a bedspread or a smooth mat in Sukasanam or Padmasanam with Pambu 
Muthirai (Bairava Muthirai) or Chin Muthirai. 
2. Close your eyes and concentrate on your breathing. 
3. Through both nostrils breath in slowly, steadily and gradually to the maximum at the 
same time  chanting the manthiram AUM in a such a way that the sound ‘A’ (i.e 
Akaram) occupies the 50% of the time taken for inspiration and ‘U’(i.e Ukaram) 20% 
and ‘M’ (i.e Makaram) the remaining 30% of the time taken in order. 
4. Repeat the process again and again for 30 to 40 times. 
Benefits:  
ü Relieves stress.  
ü Ensures sound sleep.  
ü Increases memory power and concentration.  
ü Increases exercise tolerance.  
ü Nourishes the nervous system.  
ü Purifies blood. 
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MODERN ASPECTS 
SKIN ANATOMY 
INTRODUCTION 
The integument or skin is the largest organ of the body in surface area and weight, 
making up 16% of body weight, with a surface area of 1.8 m2. It has several functions, the 
most important being to form a physical barrier to the environment, allowing and limiting 
the inward and outward passage of water, electrolytes and various substances while 
providing protection against micro-organisms, ultraviolet radiation, toxic agents and 
mechanical insults. It also acts as a reservoir for the synthesis of Vitamin D. Skin is a 
dynamic organ in a constant state of change, as cells of the outer layers are continuously 
shed and replaced by inner cells moving up to the surface. Although structurally consistent 
throughout the body, skin varies in thickness according to anatomical site and age of the 
individual. The skin consists of two layers: the epidermis and the dermis. Beneath the 
dermis lies the hypodermis or subcutaneous fatty tissue. Hair, nails, sebaceous, sweat and 
apocrine glands are called as derivatives of skin. Wounding affects all the functions of the 
skin. 
A.EPIDERMIS 
The epidermis is mainly composed of layers of keratinocytes but also containing 
melanocytes, Langerhans cells and Merkel cells. The thickness of the epidermis varies 
indifferent types of skin. It is the thinnest on the eyelids at 0.05 mm and the thickest on the 
palms and soles at 1.5 mm. The epidermis contains no blood vessels and is entirely 
dependent on the underlying dermis for nutrient delivery and waste disposal via diffusion 
through the dermoepidermal junction. The epidermis is a stratified squamous epithelium 
that consists primarily of keratinocytes in progressive stages of differentiation from deeper 
to more superficial layers.It contains 5 layers. From bottom to top the layers are named: 
·  Stratum Basale 
·  Stratum Spinosum 
·  Stratum Granulosum 
·  Stratum Lucidum 
·     Stratum Corneum 
The stratum germinativum or the basal layer is immediately superficial to the 
dermoepidermal junction. This single cell layer of keratinocytes is attached to the 
basement membrane via hemi desmosomes. 
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Specialized Epidermal Cells 
There are three types of specialized cells in the epidermis 
                  · The melanocyte produces pigment (melanin). 
      · The Langerhan’s cell is the frontline defence of the immune system in the skin. 
                  · The Merkel's cells function is not clearly known. 
EPIDERMAL APPENDAGES 
Epidermal appendages are intradermal epithelial structures lined with epithelial 
cells with the potential for division and differentiation. Epidermal appendages include 
sebaceous glands, sweat glands, apocrine glands, mammary glands, and hair follicles. 
They often are found deep within the dermis, and in the face may even lie in the 
subcutaneous fat beneath the dermis. The following glands and structures are found in the 
epidermis: 
SWEAT GLANDS 
There are thought to be over 2.5 million on the skin surface and they are present 
over the majority of the body. They are located within the dermis and are composed of coiled 
tubes, which secrete a watery substance. They are classified into two different types: eccrine 
and apocrine. 
ECCRINE GLANDS  
They are found all overthe skin especially on the palms, soles, axillae and forehead 
except margins of the lip, labia minora, glans penis and inner aspect of the prepuce. They are 
under psychological and thermoregulatory center in the hypothalamus control. Sympathetic 
(cholinergic) nerve fibres innervate eccrine glands. The normal function of the sweat gland 
is to produce sweat, which cools the body by evaporation. The watery fluid they secrete 
contains chloride, lactic acid, fatty acids, urea, glycoproteins and mucopolysaccharides. Each 
gland consists of a coiled secretory  intradermal portion that connects to the epidermis via 
a relatively straight distal duct. 
APOCRINE GLANDS 
Apocrine glands are larger, the ducts of which empty out into the hair follicles. These 
are the scent glands. They are present in the axillae, anogenital region and areolae .They 
become active at puberty, producing an odourless protein-rich secretion which when acted 
upon by skin bacteria gives out a characteristic odour. These glands are under the control of 
sympathetic (adrenergic) nerve fibres. Apocrine glands are similar in structure but not 
identical to eccrine glands. Modified apocrine glands are found in the ear canal (ceruminous 
glands), eyelids (Moll's glands), and in the breasts (mammary glands). 
. 
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SEBACEOUS GLANDS 
These glands are derived from epidermal cells and are closely associated with hair 
follicles especially those of the scalp, face, chest and back. They are not found in hairless 
areas.They are small in children, enlarging and becoming active at puberty, being sensitive 
to androgens. They are largest and most concentrated in the face and scalp where they are 
the sites of origin of acne. They produce an oily sebum by holocrine secretion in which the 
cells break down and release their lipid cytoplasm. Sebum lubricates the skin to protect 
against friction and makes it more impervious to moisture. 
HAIR  
They are found over the entire surface of the body except the soles of the feet, 
palms, glans penis, clitoris, labia minora, mucocutaneous junction, and portions of the 
fingers and toes.Hair differs in length, thickness and colour. It grows about 1-2 cm per month. 
The growth of Hair is controlled by endocrine.Hair follicles are complex structures formed 
by the epidermis and dermis.. The base of the hair follicle, or hair bulb, lies deep within 
the dermis and, in the face, may actually lie in the subcutaneous fat. This accounts for the 
remarkable ability of the face to re-epithelialize even the deepest cutaneous wounds.Each 
hair follicle is lined by germinative cells, which produce keratin and melanocytes, which 
synthesise pigment. The hair shaft consists of an outer cuticle, a cortex of  keratinocytes and 
an inner medulla. The root sheath, which surrounds the hair bulb, is composed of an outer and 
inner layer. An erector pili muscle is associated with the hair shaft and contracts with cold, 
fear and emotion to pull the hair erect, giving the skin `goose bumps'. 
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NAILS 
It consists of a dense plate of hardened keratin between 0.3 and 0.5 mm thick. It covers 
the dorsal surfaces of the distal phalanges of the fingers and toes.  The nail is made up of a nail 
bed, nail matrix and a nail plate. The surface of the skin on which the nail rests is known as the 
nail bed .The nail matrix is composed of dividing keratinocytes, which mature and keratinise 
into the nail plate. The visible portion of the nail is called the nail plate. The proximal edge of 
the nail is known as the nail root. The nail plate appears pink due to adjacent dermal 
capillaries and the white lunula at the base of the plate is the distal, visible part of the matrix. 
The thickened epidermis which underlies the free margin of the nail at the proximal end is 
called the hyponychium. Fingernails grow at 0.1mm per day; the toenails more slowly grower 
than fingernails. 
B. DERMIS 
The area of supportive connective tissue between the epidermis and the underlying 
subcutis. The dermis varies in thickness, ranging from 0.6 mm on the eyelids to 3 mm on 
the back, palms and soles. It is found below the epidermis and is composed of a tough, 
supportive cell matrix. Two layers comprise the dermis: 
· a thin papillary layer (superficial layer) 
· a thicker reticular layer (deeper layer) 
The papillary dermis lies below and connects with the epidermis. It contains thin 
loosely arranged collagen fibres. Thicker bundles of collagen run parallel to the skin 
surface in the deeper reticular layer, which extends from the base of the papillary layer to 
the subcutis tissue.The dermis is composed of collagen, elastic tissue and reticular fibers. 
Collagen fibres make up 70% of the dermis, giving it strength and toughness. Elastin 
maintains normal elasticity and flexibility while proteoglycans provide viscosity and 
hydration. The primary function of the dermis is to sustain and support the epidermis.  
The reticular layer also contains fibroblasts, mast cells, nerve endings, lymphatics, 
and epidermal appendages. Surrounding the components of the dermis is the gel-like 
ground substance, composed of mucopolysaccharides (primarily hyaluronic acid), 
chondroitin sulfates, and glycoproteins. The deep surface of the dermis is highly irregular 
and borders the subcutaneous layer, the panniculus adiposus, which additionally cushions 
the skin. The fibroblast is the major cell type of the dermis. These cells produce and 
secrete procollagen and elastic fibers. Procollagen is terminally cleaved by proteolytic 
enzymes into collagen that aggregates and becomes cross-linked. 
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Specialized Dermal Cells 
The dermis contains many specialized cells and structures: 
·  The hair follicles are situated here with the Arrector pili muscles that attaches to 
each follicle. 
·  Sebaceous (oil) glands and apocrine (scent) glands are associated with the follicle. 
· This layer also contains eccrine (sweat) glands, but they are not associated with 
hair follicles. 
· Blood vessels and nerves course through this layer. The nerves transmit sensations 
of pain, itch, and temperature. 
·  There are also specialized nerve cells called Meissner's and Vater-Pacini 
corpuscles that transmit the sensations of touch and pressure. 
DERMO-EPIDERMAL JUNCTION/BASEMENT MEMBRANE 
This is a complex structure composed of two layers. Abnormalities here result in 
the expression of rare skin diseases such as bullous pemphigoid and epidermo-lysis 
bullosa. The structure is highly irregular, with dermal papillae from the papillary dermis 
projecting perpendicular to the skin surface. It is via diffusion at this junction that the 
epidermis obtains nutrients and disposes of waste. The dermoepidermal junction flattens 
during ageing which accounts in part for some of the visual signs of ageing.The 
dermoepidermal junction is an undulating basement membrane that adheres the epidermis 
to the dermis. It is composed of 2 layers, the lamina lucida and lamina densa. The lamina 
lucida is thinner and lies directly beneath the basal layer of epidermal keratinocytes. The 
thicker lamina densa is in direct contact with the underlying dermis.  
C. SUBCUTANEOUS TISSUE 
This layer is important in regulation of skin temperature and the body. This is made up 
of loose connective tissue and fat, which can be up to 3 cm thick on the abdomen. 
BLOOD AND LYMPHATIC VESSELS 
The dermis receives rich blood supply. A superficial artery plexus is formed at the 
papillary and reticular dermal boundary by branches of the subcutis artery. Branches from this 
plexus form capillary loops in the papillae of the dermis, each with a single loop of capillary 
vessels, one arterial and one venous. The veins drain into mid-dermal and subcutaneous 
venous networks. Dilatation or constriction of these capillary loops plays a direct role in 
thermoregulation of the skin. Lymphatic drainage of the skin occurs through abundant 
lymphatic meshes that originate in the papillae and feed into larger lymphatic vessels that 
drain into regional lymph nodes. 
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NERVE SUPPLY 
The skin has a rich innervation with the hands, face and genitalia having the highest 
density of nerves. All cutaneous nerves have their cell bodies in the dorsal root ganglia and 
both myelinated and non-myelinated fibres are found. Free sensory nerve endings lie in the 
dermis where they detect pain, itch and temperature. Specialised corpuscular receptors also lie 
in the dermis allowing sensations of touch to be received by Meissner's corpuscles and 
pressure and vibration by Pacinian corpuscles. The autonomic nervous system supplies the 
motor innervation of the skin: adrenergic fibres innervate blood vessels, hair erector muscles 
and apocrine glands while cholinergic fibres innervate eccrine sweat glands. The endocrine 
system regulates the sebaceous glands, which are not innervated by autonomic fibres. 
FUNCTIONS OF SKIN: 
· Protective Function 
· Immunological Function 
· Sensory Functions 
· Secretion and Excretion 
· Synthesis of Vitamin D 
· Body heat regulation 
· Endocrine function 
· Storage function of skin 
31 
 
 
ECZEMA 
Definition 
Eczema is a non - contagious chronic skin disease which is characterized by 
erythema, scaling, oedema, oozing and vesiculation.  
Ref: Practice of Dermatology-Bhel 
The term eczema is derived from the Greek, meaning "to boil out." The name is 
particularly apt since to ancient medical practitioners it may have appeared that the skin 
was "boiling". Today the usage is rather imprecise since it is frequently used to describe 
any sort of dermatitis (inflammatory skin conditions). Not all dermatitis is eczematous. All 
eczematous dermatitis has a similar appearance. The itching may be so intense that it 
interferes with sleep. 
Eczema occurs when skin is more sensitive to certain substances than normal. The 
appearance, severity, symptoms and triggers of eczema vary between individuals. There is 
currently no cure for eczema, but eczema can be controlled with regular medical care and 
a good treatment plan. Some types of eczema can be prevented by avoiding stress, 
irritants, and things that cause allergic reactions. 
Eczema is generally not a serious condition, but there is a potential for 
complications, such as a secondary bacterial or fungal infection of the eczema rash.  Early 
diagnosis and treatment can help reduce your risk for complications. 
      Eczematous diseases are very common with an estimated prevalence of more than 
10% in the general population. According to statistics 15-25% of all dermatological 
patients suffer from eczema. 
For the age group 6 to 7 years, the prevalence of current eczema ranged from 0.9% in 
India to 22.5% in Ecuador, with new data showing high values in Asia and Latin America. 
For the age group 13 to 14 years, prevalence values ranging from 0.2% in China to 24.6% 
in Columbia with the highest values in Africa and Latin America. Current eczema was 
lower for boys than girls (odds ratio, 0.94 and 0.72 at ages 6 to 7 years and 13 to 14 years, 
respectively.The prevalence of eczema is on the increase and currently affects 12-15% of 
all school-age children and 2-10% of adults.  
  Ref:www.jacionline.org/article/S0091-6749(09)01535-8/abstract 
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AETIOLOGY 
 The causes of eczema are unknown. Effective eczema management requires a 
combination of prevention and treatment. In addition to preventing eczema flare-ups by 
minimizing any known triggers, treatment is also an important part of eczema 
management. Basically, two factors cause dermatitis and eczema. 
· Allergic or sensitive skin. 
· Exposure to an irritant. 
The dermatologist Darier has said that, “There is no eczema but an eczematous patient”. 
The general predisposing causes are Age, Genetic and familial predisposition, ₃General 
debility, Climate, Psychological stress, Local Factors, Food as allergens. 
Age 
Eczema sometimes occurs in infancy, at puberty and at the time of menopause. 
Genetic & familial predisposition 
There is usually a personal or family history of allergy, viz asthma, eczema and 
hay fever. 
General debility 
Lowering of resistance of the individual in general debility predisposes to eczema. 
Climate 
Climate extremes like heat and severe cold. 
Psychological stress 
Local factors 
· Xeroderma or ichthyosis, a greasy skin hyperhidrosis, varicose veins. 
· Direct contact with pet and domestic animals (especially their saliva or fur) 
and indirect contact with animal dander. 
· Rough, scratchy, tight clothing, especially clothes made of wool (or) stiff 
fabrics.  
· The frequent use of soaps and cleaning products that tend to affect the 
shiny nature of the skin. 
Food as allergens 
a) Animal sources 
● Cow’s milk – Casein and lactoglobulin are known to be the major allergen. 
Egg white is the allergising factor. 
● Any species of fish can be responsible for allergic reactions. 
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● Meats of all kinds –It has been observed in cases of hypersensitiveness to 
the meat of a certain animal, the liver, pancreas, kidney and brain. 
b) Plant sources 
● Wheat flour – allergic reaction due to wheat gluten. 
● Some workers in glue factories using soya flour as an ingredient of glue, 
develop severe allergic symptoms. 
● Peas, beans and lentils have been reported to produce allergic reactions in 
some individuals. 
● Consumption of edible mushrooms sometimes may cause allergic reactions. 
● The vegetables which have been found to produce allergic reactions in 
some individuals are carrot, spinach, cabbage, onion, garlic, sweet potato, 
cauliflower and pumpkin. 
● Among the fruits, strawberries, bananas, oranges, grapes and apples are the 
principal offenders. 
● Occasionally allergic reactions can occur due to consumption of pears, 
cherries, plums, gooseberries. 
● Citrus fruits and tomatoes may cause atopic allergy. 
c) Beverages 
Allergic actions are due to traces of foreign substances derived from food 
materials employed in the preparations or clarifying the beverage, such as; Barely 
malt and yeast in beer & Rye corn and wheat in whisky. 
Cosmetics 
Common ingredients in cosmetics such as perfumes, face creams, deodarents, 
hair dye, shampoos, parabens, benzocaine, lanolin, thimersol, etc. 
Clothing      
Rubber chappals, spectacle, resins, frames, furs, nylon, synthetic dyes. Most   
buttons of    formaldehyde resins, epoxy resins are all common sensitizers. 
Medicaments   
This include Sulphonamides, Penicillin, Streptomycin, Cocaine, Tincture benzoin, 
Neomycin, Furacin, Phenargan cream & sticking plaster etc. Dettol, savlon,cetavlon are 
primary irritants. 
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INDUSTRIAL AND OCCUPATIONAL AGENTS    
Occupational       
· Agriculturists  - Plants, weeds, fertilizers, oils. 
· Automobile  - Oil, petrol, solvent, grease, paints, thinner. 
· Building workers  - Cement, lime, paints, insecticides, kerosene oil. 
· Chemical Pharmaceutical 
industries    - Dyes, Chemicals, explosives, solvents, 
  disinfectants, detergents 
· Coal miners  - Mechanical injuries 
· Dentists   - Cocaine and its derivatives 
· Engineering industries - Cutting oils, solvents, detergents   
· Housewives  - Soaps, detergents, vegetables, fruits, nickel, 
  polishes, artificial flavours, dyes, flowers, keys.  
· Nurses and Doctors - Iodine, streptomycin, chlorpromazine, tincture. 
· Painters   - turpentine, paints, detergents 
· Photographers  - metal,bichromate 
· Plastic factory workers -resins, hardeners, solvents, glass, cellulose esters 
· Rubber workers  -  T.M.T, M.B.T, dyes, glues, oils 
· Tannery workers  - Chromate, formaldehyde, arsenic, alkalies, acids. 
· Textile workers  - Formaldehyde, solvents, dyes, bleaches. 
Ten common allergens come across in practice 
· Paraphenylene diamine 
· Nickel sulphate 
· Pottasium dichromate 
· Parthenium hysterophorus 
· Nitrofurazone ointment 
· Neomycin sulphate 
· Formaldehyde 
· Turpentine 
· Garlic 
· Epoxyresin 
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EXACERBATING FACTORS 
· Irritants  - Physical, chemical or electrical 
· Sensitizers  - Plants, clothing, cosmetics, medicaments, infection, diet. 
· External infections  - Streptococci, Staphylococci, fungus. 
· Mental and emotional conflicts.  
· Internal septic focus shedding toxins or causing bacteremia. 
· Diet and state of digestion. 
· Diathesis  - Allergic, Xerodermic, hyperhidrotic or seborrhoeic 
· Drugs   - given for the disease or otherwise. 
· State of local or general nutrition 
· Climate  -   Temperature and humidity 
 Scratching, Chemical trauma, Climate, Stress and Strains keep the process 
going with the result that eczema becomes chronic. 
It is still controversial whether the endogenous factors like diet, emotional strain 
and stress, focal sepsis, state of digestion, nutrition are more important than exogenous 
factors like infection, irritants and sensitizers (or) vice versa. In practice mixed eczemas 
are much more common than pure entities. History and clinical observation are very 
important in establishing the exact etiological diagnosis. 
IMMUNOLOGY 
Immunology is a science which deals with the body’s response to antigenic 
challenge. These mechanisms are involved in the protection of the body against infectious 
agents but periodically they can also cause damage. 
Sensitization develops when a different clone of T-lymphocytes is activated. The 
sensitized T-lymphocytes yield two sub populations of lymphocytes. Memory cells those 
are responsible for the persistence of contact allergy. Effector cells that initiate the allergic 
response when appropriately challenged. 
PATHOPHYSIOLOGY 
Allergy & hypersensitivity 
Both terms are synonyms. The concept of hypersensitivity was first introduced by 
Portier and Richet. The term allergy was first used by Von Pirquit (1874 - 1929) to denote 
changed reactivity of the body to outside chemicals. Changed reactivity in this context 
means that the body behaves in a particular way when it is exposed to a chemical 
substance known as ‘Allergen’ for the first time, but changes the nature of its reaction  
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when it is exposed for the second and subsequent times. This change is due to proteins 
known as antibodies. The moment, the allergen IgE combination stimulates the mast cells 
which unload their chemical contents into the surrounding tissues. These chemicals 
(mediators of allergy) cause the manifestations of allergy such as erythema, wheal and 
flare reaction. Flare is due to dilatation of arterioles by local axon reflex and the liberation 
of vasodilator substances like histamine and its by products like serotonin, bradykinin, 
acetylcholine from the injured cells like mast cells and basophils etc., The manifestation 
of hypersensitivity may be immediate (or) delayed type. 
Cutaneous Allergy 
In the skin two important but different allergic reactions occur. 
Dermal reaction 
· Dermal reaction is commonly seen in urticaria. 
· The causative antigen reaches the skin through ingestion, inhalation or injection of 
protein substances and the reacting antibodies circulate in the serum. 
· Allergic reaction takes place in the dermis. 
· Intra dermal tests (scratch) show reactivity. 
Epidermal reaction 
· It is seen in allergic dermatitis or eczema. 
· The  causative  substance  reaches  the  skin  by  contact     intra  dermal  allergic  
tests are negative. 
· But patch test shows reactivity. 
· Allergen + Epidermal protein – Antigen formation (probably in lymph glands) 
· Circulation   - Fixed in epidermal cells on next occasion. 
· Allergen + Antibodies – Eczematous reaction (In epidermis) 
· A severe local reaction may result in auto-intoxication & dissemination of 
eczematous reaction to distant parts. 
Status Eczematicus 
It is believed that in case of severe allergic states, a state may develop when the 
patient becomes hypersensitive to even unrelated substances resulting in status 
eczematicus comparable to status asthmaticus in practice of internal medicine. 
Reaction time 
It is the time taken by a sensitized individual to manifest a clinical reaction 
following contact with a known sensitizer. It is usually 12-24 hours but may vary from 
one hour to 120 hours. 
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Dissemination reaction 
It is a fleeting erythematous macular reaction involving the face and flexures, 
caused by the escape of lymphokines in the circulation resulting in vasodilatation at 
distant site. 
Cause of recurrence 
Flare reaction is reactivation of a previously healed site of a contact dermatitis or a 
positive patch test reaction following renewed challenge or exposure to the same allergen 
at another site. This is because of persistence of sensitized lymphocytes at the site of 
earlier reaction, which react to minute amounts of antigen sometimes escape in the 
circulation form the new site and find its way to the old site. Further it must be realised 
that Dermal or epidermal sensitization affects the entire integument and this sensitization 
once acquired is lifelong. According to some, a degree of bloating in reactivity may be 
seen with the passage of time. 
CLINICAL FEATURES 
Eczema is a specific type of allergic subcutaneous manifestation of antigen 
antibody reaction. It is characterized by superficial inflammatory oedema of the epidermis 
associated with vesicle formation. Itching varies from mild to severe paroxysms which 
may even interfere with work and sleep. The natural history of eczema is represented as 
follows: 
It can differ in severity, frequency and duration among individuals. Symptoms 
frequently begin in infancy, reoccur during childhood, and disappear during adulthood. 
Flare-ups, however, can be unpredictable throughout your lifetime. 
Skin areas affected by eczema can exhibit a variety of characteristics including: 
· Blistering 
· Darkening of the area of skin affected by eczema (hyperpigmentation) 
· Dryness 
· Flaking 
· Inflammation (swelling, irritation and warmth) 
· Scaling 
· Small red bumps 
· Thickening of the affected skin due to frequent scratching. Scratching the area 
affected by eczema generally does not relieve the itching and can lead to increased 
inflammation, more intense itching, and harder scratching. 
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 CLASSIFICATION 
· Atopic eczema 
· Seborrhoeic eczema 
· Discoid eczema 
· Asteatotic eczema 
· Gravitational eczema 
· Neurodermatitis  
· Infectious   eczematoid dermatitis 
· Photodermatitis 
Detergents, alkalies, acids, solvents and abrasive dusts are common causes. Irritant 
eczema accounts for the majority of industrial cases and work loss. The elderly, those with 
fair and dry skin and those with an atopic background are especially vulnerable. Napkin 
eczema in babies is common and due to irritant ammoniacal urine and faeces. Strong 
irritants elicit an acute reaction at the site of contact whereas weak irritants most often 
cause chronic eczema, especially of the hands after prolonged exposure. 
Allergic contact dermatitis 
Definition 
Allergic contact dermatitis is an eczematous rash that develops after contact with 
an agent due to delayed cellular hypersensitivity. 
 Aetiology (Allergens) 
They are classified into two groups 
· Non proteins - Dyes, oils, resins, coal for derivates, rubber, cosmetics. 
· Proteins - Bacterial products, fungi and parasites are included in this group. 
Persons may be exposed to allergens for years before finally developing 
hypersensitivity. The sensitized   area   although   usually   generalized    may   be    
strictly localized. 
Eg: Eczema of the ear lobes, wrists and back due to contact with nickel in costume,     
jewellery. 
Some common skin allergens 
· Nickel    -Jewellery, Jean stuels, bra clips. 
· Dichromate   -Cement leather, matches. 
· Neomycin, benzocaine - Topical applications. 
· Parabens   - Preservative in cosmetics and creams. 
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· Wool alcohols   - Lanolin, Cosmetics, creams. 
· Epoxy resin   - Resin adhesives. 
· Rubber    -chemicals Clothing, shoes, tyres. 
· Colophony   - Sticking plaster, collodion. 
· Paraphenylene diamine - Hair dye, clothing. 
· Balsam of peru  - Perfumes, citrus fruits. 
Prognosis 
Contact dermatitis usually clears up without complications in 2 or 3 weeks. 
However, it may return if the substance or material that caused it cannot be found or 
avoided.You may need to change your job or job habits if the disorder is caused by 
occupational exposure. 
Complications: 
Bacterial skin infections may occur. 
Photo dermatitis 
Photo dermatitis means photo sensitization of the skin after contact with plants 
which have either photo toxic or photo allergic action. Dermatitis in this condition, is 
confined to the exposed parts of the body viz, face, neck, “v” of the chest, hands and 
external surfaces of the fore arms and dorsum of foot and the adjoining parts of legs. 
The common causes of photo dermatitis are, 
· Drugs like sulphonamides, chlorpromazine, promethazine, declamycin, terramycin,   
chlorthiazide, diuretic, different hypotensive and antidiabetic drugs. 
· Foods like figs and buck wheat. 
· External application of bithionol etc., 
· Plants and their products like parsnips, cow parsnips meadow grass mustards, lime 
oil, psoralea, bergmot oil etc. 
Endogenous eczema 
There is no evidence of external irritants or allergens. In endogenous eczema part 
of the body becomes sensitized to internal body products, toxins from focal sepsis, 
metabolites that are products of digestion (or) elements of diet and drugs with or without 
familial predisposition. 
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ATOPIC ECZEMA 
It is also called asthmatic eczema syndrome.Atopic dermatitis is a long-
term (chronic) skin disorder that involves scaly and itchy rashes. Atopic dermatitis is due 
to a hypersensitivity reaction (similar to an allergy) in the skin, which leads to long-term 
swelling and redness (inflammation) of the skin. People with atopic dermatitis may lack 
certain proteins in the skin, which leads to greater sensitivity. Atopic dermatitis is most 
common in infants. It may start as early as age 2 to 6 months. People with atopic 
dermatitis often have asthma or seasonal allergies. There is often a family history of 
allergic conditions such as asthma, hay fever, or eczema. People with atopic dermatitis 
often test positive to allergy skin tests. 
Aetiology 
The inheritance of atopic eczema is controversial. The disorder is concordant in 
86% of monozygotic twins but in only 21% of dizygotes. Atopic diseases show maternal 
imprinting i.e., they are inherited more often from the mother than from the father. 
Distribution and character of rash 
Infancy 
The eczema is often acute and involves the face & trunk. 
The napkin area is frequently spared. 
Childhood 
The rash settles on the back of the knees, front of the elbows, wrists and ankles. 
Adults 
The face and trunk are once more involved and lichenification is common. 
Diagnostic criteria 
Itchy skin and at least three of the following: 
Ø History of itch in skin creases (or cheeks if < 4 years). 
Ø History of asthma / hay fever (or in a first – degree relative if    < 4 years). 
Ø Dry skin (Xeroderma). 
Ø Visible flexural eczema (cheeks, forehead, outer limbs if < 4 years). 
Ø Onset in first 2 years of life. 
Prognosis: 
In children, the condition often clears beginning at around age 5 - 6, but flare-ups 
will often occur. In adults, it is generally a long-term or returning condition. 
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Complications: 
 Infections of the skin caused by bacteria, fungi, or viruses. 
Permanent scars. 
SEBORRHOEIC ECZEMA 
Synonym: Dandruff; Seborrheic eczema; Cradle cap 
Seborrhoeic dermatitis is a common, inflammatory skin condition that 
causes flaky, white to yellowish scales to form on oily areas such as the scalp or inside the 
ear. It can occur with or without reddened skin. Cradle cap is the term used when 
seborrheic dermatitis affects the scalp of infants. 
Causes: 
It is due to pityrosporum ovale infection of the skin. Seborrheic dermatitis appears 
to run in families. Stress, fatigue, weather extremes, oily skin, infrequent shampoos or skin 
cleaning, use of lotions that contain alcohol, skin disorders (such as acne), or obesity may 
increase the risk. 
In its milder forms it is the same as dandruff whereas when severe it may resemble 
psoriasis.Human immunodeficiency virus (HIV) has also been linked to increased cases of 
seborrheic dermatitis. Symptoms of seborrheic dermatitis include: 
· Skin lesions- Greasy, oily areas of skin 
· Plaques over large area 
· Skin scales - white and flaking, or yellowish, oily, and adherent - "dandruff" 
· Itching - may become more itchy if infected 
· Mild redness 
· Hair loss 
Prognosis: 
Seborrheic dermatitis is a chronic (life-long) condition that can be controlled with 
treatment. It often has extended inactive periods followed by flare-ups. A more extreme 
form of this condition overlaps with psoriasis of the scalp and is called sebopsoriasis. 
Complications: 
· Psychological distress, low self -esteem, embarrassment 
· Secondary bacterial or fungal infections 
DISCOID ECZEMA 
Synonym: Nummular eczema 
Nummular eczema is an allergy-related disorder in which itchy, coin-shaped spots 
or patches appear on the skin. 
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Aetiology 
The cause of nummular eczema is unknown, but there usually is a personal or 
family history of: 
· Allergies 
· Asthma 
· Atopic dermatitis 
It is relatively uncommon, and most often occurs in elderly men. 
Several things may make the condition worse, including 
· Dry skin 
· Environmental irritants 
· Stress 
· Temperature changes 
ASTEATOTIC ECZEMA 
This is frequently seen in the hospitalized elderly especially when the skin is dry, 
low humidity caused by central heating over washing and diuretics are contributory 
factors. It occurs most often on the lower legs as a rippled or crazy paving pattern of fine 
fissuring on an erythematous background. 
GRAVITATIONAL (STASIS) ECZEMA 
Persistent inflammation of the skin of the lower legs commonly associated with 
venous incompetency. The eruption is usually localized to the ankle, where oedema, 
erythema, mild scaling and brownish discoloration occur. Secondary bacterial infection 
and eventual ulceration may occur. The cause is mainly due to perivascular fibrin 
deposition and abnormal small – vessel vaso constrictive reflexes. 
NEURO DERMATITIS 
Synonym: Lichen simplex chronicus 
Affecting more  commonly neurotic people. 
Definition 
This condition may be defined as the lichenification process resulting from chronic 
scratching and rubbing of the skin under stress and anxiety. 
Clinical features 
The skin becomes thickened, infiltrated and pigmented. The criss cross markings 
become more prominent. Margins are irregular and usually well defined. 
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Common sites 
The nape of the neck, arms, ano-genital area, back of knees, legs and ankles. 
POMPHOLYX 
Synonym: Dyshidrosis, dyshidrotic eczema 
Dyshidrotic eczema is a condition in which small, usually itchy blisters develop on 
the hands and feet. Recurrent vesicles and bullae occur on the palms, palmar surface of the 
fingers and soles. It is most common in adult life (20-40 yrs). But is often idiopathic. 
Symptoms: 
· Small fluid-filled blisters called vesicles appear on the fingers, hands, and feet. 
They are most common along the edges of the fingers, toes, palms, and soles. 
These blisters can cause intense itching and scaly patches of skin that flake 
constantly or become red, cracked, and painful. 
· Scratching leads to skin changes and skin thickening. Large blisters may cause 
pain. 
Provoking factors are: 
Heat 
Stress 
Nickel ingestion 
Prognosis: 
Dyshidrotic eczema normally goes away without problems, but symptoms may 
return later. Excess scratching may lead to thick, irritated skin, which is more difficult to 
treat and takes longer to heal. 
Complications: 
· Pain and itching that limits the use of the hands 
· Secondary bacterial infection 
RADIODERMATITIS 
It implies dermatitis produced by excessive doses of X-rays received by the skin. 
INFECTIOUS ECZEMATOID DERMATITIS 
Synonym: Infective eczema 
This results from sensitization to certain organisms like streptococci, 
staphylococci, dermatophytes and yeast organisms. 
Common sites: Body folds, hair follicles.
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Sub divisions 
1) Post traumatic infective eczema 
It starts with a crack in the integrity of the skin brought on by an injury, a blister, an 
insect bite or exposure to a cold wind etc. 
Eczematization secondary to acute tinea, particularly tinea pedis is frequently seen. It 
starts from digital spaces and spreads to the dorsum of the foot or the soles. 
2) Follicular infective eczema 
It involves hairy region like the scalp, beard and legs. It starts usually with pityriasis 
capitis which gets complicated by one (or) several itchy patches of oozing, pits and crusting. 
The eczema spread to fore head, retro auricular folds and cheeks. streptococi, staphylococci 
and less so Pityrosporon organism are the causatives. 
3) Flexural infective eczema 
The flexures are the sites of predilection. It starts with a crack in the depth of the fold 
and two opposing surfaces are equally affected. The inner part looks moist and red and only 
at the periphery is crusting clearly evident. 
Infantile eczema 
This occurs in children between the ages of three months and two years. It usually 
starts on the cheeks, spreading slowly to forehead, chin, scalp, arms, trunk, legs, buttocks and 
in the groins, napkin rash like dermatitis may develop. 
Clinical features 
Characterized by erythema, vesicles, exudation and crusting pruritus is a prominent 
symptom, it comes in spasms. To start with the infants are usually plump. 
Complications:  
When left untreated, eczema can develop into an escalating cycle of itching, scratching 
and inflammation. In some cases, the excessive scratching can introduce bacteria or fungus 
into the layers of the skin, resulting in infections that can be serious in some people. 
Complications include: 
· Bacterial or fungal infection of the skin 
· Cellulitis (an infection of the skin and surrounding tissues caused by a 
growing bacterial or fungal infection) 
· Open sores and lesions 
· Permanent change in skin texture or scarring and Permanent skin discoloration 
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Lifestyle changes and general treatments for eczema 
· Avoiding alcohol and caffeine 
· Avoiding hot tubs, steam baths, saunas, and chlorinated swimming pools 
· Avoiding scratchy clothes 
· Drinking plenty of fluids 
· Getting skin patch testing, in which small amounts of common allergens are 
applied methodically to the skin to determine what substances are triggering 
the allergic response that leads to the eczema 
· Minimizing skin dryness by using lotion specifically designed for sensitive 
skin 
· Preventing flare-ups by avoiding exposure to the specific allergen or allergens 
that induce the condition 
· Using a perfume-free moisturizer 
· Using ice bags or cool wet compresses to help relieve itching and 
inflammation 
· Using mild soaps and not over washing or harshly scrubbing skin 
INVESTIGATIONS OF ECZEMA 
Patch test 
Patch tests detect type IV (delayed or cell-mediated ) hypersensitivity. It is common 
practice for a battery of around 20 common antigens, including common sensitizers such as 
nickel, rubber and fragrance mix to be applied to the skin of the back under aluminium discs 
for 48 hours. The sites are then examined for a positive reaction 24 hours later and possibly 
again a further 24 hours later. The positive test is revealed by the development of an 
eczematous patch with erythema swelling and vesicles at the site of application. 
Patch test reaction is graded in the following degrees 
+ - Only redness 
++ - Marked redness and swelling 
+++ - Marked redness, swelling and papules 
++++ - redness, oedema and vesicles 
Specific IgE levels to antigens can be measured in serum by a specific radio allergic sorbent 
test (RAST). These are occasionally performed to support diagnosis of atopic eczema and to 
determine specific environmental allergens, eg. pet dander, horse hair, house dust mite, 
pollens and foods. 
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Prick tests 
Prick tests are a way of detecting cutaneous type I (immediate) hypersensitivity to 
various antigens such as pollen, house dust, mite or dander. 
Bacterial and Viral swabs for microscopy and culture 
These are useful tests in suspected secondary infection skin swabs for bacteriological 
assessment will invariably reveal the presence of bacteria. In the case of recurrent impetigo in 
a child with atopic eczema, bacterial swabs should be taken from carrier sites (axillae and 
groin) from both the affected individual and house hold members. 
Hints of diagnosis for all eczemas 
· Nature   of   the   lesions -   size,   shape,   itching,   number   of   papules,   
pustules, erythema etc., 
· Distribution - sites of lesion. 
· History of occupation. 
· History of exposure to allergens - i.e. Chemicals, plants, soap, etc., 
· Personal and family History of such diseases - e.g atopic or allergic 
eczemas 
· Climate - eg: Dyshidrosis occurs at the change of seasons particularly in 
spring, summer. 
· Patch tests (allergy test) in allergic/ atopic eczemas. 
· Biopsy in rare cases when the lesions do not respond to treatment. 
PROGNOSIS OF ECZEMA 
Dermatitis and eczema are as rule curable conditions. Eczema are ineffective except 
when they are leave scars. The patient needs reassurance of these points. It must be 
remembered that epidermis is an ectodermal structure and so takes time to heal. Energetic 
treatment is to be strongly discouraged. Acute eczemas heal readily in about 1-4 weeks with 
treatment. Chronic eczemas in which anatomical and functional changes set in take time to 
disappear. Disseminated and generalized eczemas are not only slow to heal, but are 
accompanied by ill health. Infantile and atopic eczemas are troublesome and uncomfortable. 
The former lasts till the age of twenty five or even though life. Its course is marked by 
spontaneous remissions and exacerbations. Psychogenic stresses climate extremes and poor 
health aggravate eczema. The cure of these conditions is retarded in tropical countries by 
heat, humidity and the prevalent unhygienic conditions. 
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The SCORAD index 
A = spread.../100 
B = intensity.../18 
C = subjective symptoms.../20 
SCORAD calculation: A/5 + 7.B/2 + C 
1.Extent criteria 
2.Intensity criteria 
o Erythema : stage 1 / stage 2 / stage 3 
o Edema / papulation : stage 1 / stage 2 / stage 3 
o Oozing / crusting : stage 1 / stage 2 / stage 3 
o Excoriation : stage 1 / stage 2 / stage 3 
o Lichenification : stage 1 / stage 2 / stage 3 
3.Subjective symptoms 
The two most representative items concerning the quality of life of patients are : 
o Pruritus 
o Insomnia 
SCORAD is a clinical tool for evaluating the severity of atopic dermatitis in order 
to provide better management of patients. 
GRADES OF ECZEMA: 
A useful way to classify eczema is based on the degree of activity and the duration 
the eczema has been active. 
1. Acute 
Acute in medical language means of rapid onset. Often conditions that come on over a 
short period of time are also quite vigorous in their activity, although strictly speaking acute 
should not be taken to be another word for severe. Acute eczema therefore would be an area 
that recently flared up and would be red, probably also have blisters and possibly some 
oozing or crusts. 
2. Chronic 
Chronic properly means long-standing. Once the initial phase of activity has died 
down a bit of skin that has been eczematous for a while is dry, scaly, thickened and cracked. 
3. Infected 
At any stage of eczema it can become infected. This won’t always be obviously 
different from acute eczema unless there are pus-filled blisters. With experience one can 
usually discern the golden crust of infection and pick up the other clues that suggest infection. 
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PREPARATION OF TRIAL DRUGS  
METHOD OF PREPARATION : 
INTERNAL MEDICINE: KUKKILAATHI CHOORANAM 
Ingredients: 
 Purified Chukku (Zingiber officinale, Rosc)    - 1 Palam(35gms)  
 Purified  Milagu  (Piper nigrum, Linn)    - 1 Palam (35gms) 
 Purified  Thippili (Piper longum, Linn)    - 1 Palam (35gms) 
Purified Karunjeeragam  (Nigella sativa,Linn)  - 1 Palam (35gms) 
 Purified Kukkil (Vateria indica, Linn)     - 5 Palam(175gms) 
 Purified Vellarugu (Enicostemma axillare,(Lam)Raynal ) - 3 Palam (105gms)                                                        
PURIFICATION OF RAW DRUGS: 
Purification of Chukku- Dried Ginger : :   
Soak it in limestone water for a period of time, dry it and the outer layer is peeled off.                     
                        Ref: Sarakku Suthi Sei Muraikal  Pg. No-28 
Purification of Milagu -Black Pepper :   
Soak it in butter milk for a period of 1 saamam(3hours) and dry it                                                     
          Ref: Sikicha Rathna Deepam  Pg. No-28 
Purification of Thippili -Long pepper:  
Soak it in lime juice and dry it                                                                                                              
                                                                   Ref: Sikicha Rathna Deepam  Pg. No-28 
Purification of Karunjeeragam -Black Cumin:                                                           
Cleaned, dried in sunlight and then fried in low flame. 
      Ref: Sikicha Rathna Deepam  Pg. No-30 
Purification of Kukkil: 
Boil it in tender coconut water   
     Ref: Sarakku  Suthi Sei Muraikal  Pg. No-4 
Purification of Vellarugu:           
Washed  with water and dried well 
                                                                        Ref: Sikicha Rathna Deepam Pg. No-28 
Method of preparation:    
   All the above mentioned ingredients are dried, finely powdered and preserved.  
 Ref – Sarabaendhira Vaidhya Muraigal Virana karappan roga sikichai(Pg no.264) 
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EXTERNAL MEDICINE: KARAPPAN MEL POOSU THYLAM 
Ingredients: 
      Puli elai (Tamarindus indica)                                                - 1 ½  Palam 
      Aavaarai verppattai   ( Rootbark of Cassia auriculata )                 - 1 ½  Palam 
      Karunjeeragam (Nigella sativa)                                                     - 1 ½  Palam  
      Milagu(Piper nigrum,linn)                                                             - 1 ½  Palam 
      Vasambu sutta kari (Ash of Acorus calamus)                               - 1 ½  Palam  
      Karbogi vidhai (Seeds of Psoralia corylifolia)                              - 1 ½  Palam  
      Aadutheenda paalai charu ( Extract of Aristolochia bracteolata)  -   Q.S 
      Gingelly oil                                                                                    - 10 Palam 
Method of preparation:    
   Aavaarai verpattai, Karunjeeragam, Milagu, Vasambu sutta kari, Karbogi vidhai, Puli 
yilai are ground well with Aadutheenda palai chaaru. The ground material is added to Sesame 
oil and kept exposed to sun light for 3 days.   
     Ref:Vaidhya sinthamani- Sikicha Rathna Deepam-Page no.205  
 
PROPERTIES OF TRIAL DRUGS 
ÍìÌ 
BOTANICAL NAME   : Zingiber officinale 
ENGLISH NAME   : Dried ginger 
FAMILY    : Zingiberaceae 
ORGANOLEPTIC CHARACTER: 
Suvai    : Kaarppu 
Thanmai   : Veppam 
Pirivu    : Kaarppu 
¦À¡ÐìÌ½õ: 
“Ý¨ÄÁó¾õ ¦¿ï¦ºÃ¢ôÒ §¾¡¼§Áô ÀõÁÆ¨Ä 
ãÄõ þ¨ÃôÀ¢ÕÁø ãìÌ¿£÷- Å¡Ä¸À 
§¾¡¼Á¾¢ º¡Ãó ¦¾¡¼÷Å¡¾ ÌýÁ¿£÷ò 
§¾¡¼õ¬ Áõ§À¡ìÌï ÍìÌ”. 
-«¸ò¾¢Â÷Ì½Å¡¸¼õ 
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CHEMICAL CONSTITUENTS: 
Camphene, Phellandrene, Zingiberine, Cineol and Borneol, Gingerol a Yellow 
Pungent body, an Oleoresin-Gingerin the active principle, other resins and starch.  
B – Sesquiphellandrene, Gingerdiols, Gingerdiacetates are also present. 
                              Ref:Indian Herbal Pharmacopoeia P - 443 
ACTIONS: 
Aromatic 
Carminative 
Stimulant 
Stomachic 
Digestive 
Á¢ÇÌ 
BOTANICAL NAME : Piper nigrum 
ENGLISH NAME  : Black pepper 
FAMILY   : Piperaceae 
ORGANOLEPTIC CHARACTER: 
Suvai   : Kaippu, kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
      Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ -µÐºýÉ¢ 
      Â¡ºÁÀŠ Á¡Ãõ «¼ý§Á¸õ ¸¡ºÁ¢¨Å 
      ¿¡ºí ¸È¢ Á¢Ç¸¢É¡ø’’.                  
                            -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS: 
A volatile alkaloid Piperine or Pipirine 5-9%, Piperidine or Piperidin 5%, Abalsamic 
volatile essential 1-2%, fat7%.Mesocarp contains chavicin, a balsamic volatile oil, starch, 
gum, Piperrettine, Piperanine, Pipericide Sarmentine, Eugenol,  
                        Ref:Indian Herbal Pharmacopoeia, P - 321 
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ACTIONS: 
Carminative 
Pungent 
Antiperiodic 
Analgesic 
Anti inflammatory 
Antioxidant 
Cyclooxygenase inhibitory activity 
                                   Ref:Indian Herbal Pharmacopoeia, P – 324 
                            Database, Vol - 190 
¾¢ôÀ¢Ä¢ 
BOTANICAL NAME : Piper longum 
SYNONYM    : Charica roxburgii 
FAMILY   : Piperacae 
ORGANOLEPTIC CHARACTER: 
Suvai   : Kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐÌ½õ: 
“¬ºÉ§¿¡ö ¦¾¡ñ¨¼§¿¡ö ¬ÅÃ½ À¢ò¾Ó¾ø 
¿¡º¢Å¢Æ¢ ¸¡¾¢¨Å§¿¡ö ¿¡ðÒØ§¿¡ö -Å£º¢ÎÅ¢ 
Âí¸Ä¡ïº Éïº¢¨¾Ôõ «õÀ¡ö «Æ¢Å¢óÐõ 
¦À¡í¸Ä¡ïº ¿í¨¸Â÷§¸¡ð§À¡ø”. 
                                          - §¾Ãý ¦ÅñÀ¡ 
CHEMICAL CONSTITUENTS: 
 Piperine (4 – 5%), Volatile Oil, Piperlonguminine,Piplartine, Sesamin, Terpenoids, 
Resin, Piperundecalidine. 
  Ref:Indian Herbal Pharmacopoeia revised – 2002, P – 310,311 
ACTIONS: 
Stimulant 
Carminative 
Alterative 
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¸Õïº£Ã¸õ 
BOTANICAL NAME : Nigella sativa Linn 
ENGLISH NAME  : Black cumin 
FAMILY   : Ranunculaceae 
ORGANOLEPTIC CHARACTER: 
Suvai   : Kaippu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐÌ½õ: 
“¸Õïº£ Ã¸ò¾¡ý ¸ÃôÀ¦É¡Î ÒñÏõ 
ÅÕïº¢Ã¡öô À£¿¢ºÓ Á¡üÚõ -«Õó¾¢É¡ø 
¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
Å¡öîº ÁÕó¦¾É§Å ¨Å”. 
                            -«¸ò¾¢Â÷ Ì½Å¡¸¼õ       
CHEMICAL CONSTITUENTS: 
Carvone, d – limonene,Cymene, Nigellone, Melanthin, Melanthigenin, Nigellidine – 
Indazole, Campesterol, Citronellyl Acetate.  
Ref: Database Vol – VI, P - 422 
· The seeds contain a fatty oil rich in unsaturated fatty acids. The two main 
unsaturated fatty acids are:      
· Linoleic acid (omega-6) 57.9% 
· Oleic acid 23.7% 
It also contains smaller amounts of saturated fatty acids. 
The two main ones present are: 
· Palmitic acid 13.7% 
· Stearic acid 2.6% 
Ref:http://www.healthymuslim.com/articles/tofeo-composition-of-
nigella-sativa-black-seed.cfm 
ACTIONS: 
Carminative 
            Stomachic 
            Anthelmintic 
            Diuretic 
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Ìì¸¢ø  
BOTANICAL NAME : Vateria indica 
ENGLISH NAME  : Damars, Sal tree 
FAMILY   : Dipterocarpaceae 
ORGANOLEPTIC CHARACTER: 
Suvai   : Kaippu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐÌ½õ:  
“¦ÀÕõÀ¡Î §Á¸õ§À¡õ §ÀÃ¡ Ð¼Ä¢ø 
«ÕõÀ¢Â Òñ½¡ÚÁ¢¨Å ÂøÄ¡ø-ÌÕõÀ¡õ 
±ÖõÒÕì¸¢ Òñº£Øõ ²Ìõ ¯Ä¸¢ø 
ºÄõÀÕÌí Ìí¸¢Ä¢Âò ¾¡ø”. 
                    - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS: 
  Resins- stilbenoids 
       Ref: Database of medicinal plants 
ACTIONS: 
Stimulant 
Expcetorant 
Diuretic 
Anti-diabetic effect 
¦ÅûÇÚÌ  
BOTANICAL NAME : Enicostemma axillare 
FAMILY   :           Gentianaceae  
ORGANOLEPTIC CHARACTER: 
Suvai   : Kaippu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
54 
 
¦À¡ÐÌ½õ: 
“ÌýÁ¦Á¡Î Å¡ö× Ì¼øÅ¡¾õ Ý¨ÄÂ¢¨Å 
¦ºýÁõÅ¢ð §¼¡Êî º¢¨¾Ôí¸¡ñ-ÅýÓ¨ÄÂ¡ö 
¯ûÙÚ¸¢ Ãó¾¢¦º¡È¢ ¦Â¡ðÊÂ º¢ÃíÌÁÚõ 
¦ÅûÇÚÌ ¾ý¨É Å¢ÕõÒ”. 
                           - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS:  
Iron, Calcium, Magnesium, Vitamin C, B Vitamins, Betacarotene, 
 (Deccan Development Society 2002). 
ACTIONS: 
 Stomachic 
 Tonic 
 Alterative 
Laxative 
Antiulcer and Anti-inflammatory Activity 
Ref:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019375/ 
Nadkarni 1976:485 
¬Å¡¨Ã §Å÷ôÀð¨¼ 
 BOTANICAL NAME : Cassia auriculata 
ENGLISH NAME  : The tanners- cassia,Avaram 
FAMILY   : Caesalpiniaceae 
ORGANOLEPTIC CHARACTER: 
Suvai   : Thuvarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐÌ½õ: 
“§Á¡¸ò¾¢ É¡§Ä Å¢¨Çó¾ºÄõ ¦Åð¨¼ÂÉø 
¬¸ò¾¢ý Òñ§½¡ ¼Õí¸¢Ã¡½¢-§À¡¸ò¾¡ý 
¬Å¡¨Ãô Àïº¸í¦¸¡û «ò¾¢ÍÃõ ¾¡¸Óõ§À¡õ 
²Å¡¨Ãì ¸ñÁ¼Á¡ §¾”. 
                       - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
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CHEMICAL CONSTITUENTS: 
Tannin, Alkaloids 
Ref: www.academia.edu/.../Elemental_analysis_and_Anti-microbial_poten 
ACTIONS: 
 Astringent 
Tonic 
Alterative 
ÒÇ¢Â¢¨Ä 
BOTANICAL NAME : Tamarindus indica 
ENGLISH NAME  : Tamarind tree 
FAMILY   : Caesalpiniaceae 
ORGANOLEPTIC CHARACTER: 
Suvai   : Kaippu, kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐÌ½õ: 
“«ØÒñ¨½ ¿£ìÌõ «¼ø§º¡¨À Á¡üÚõ 
±ØÀ¡ñÎ ¨Åô§À¡ìÌõ þôÀ¡ø-ÓØÐõ  
«Ç¢Âî º¢Åó¾¸ñ§½¡ Â¡üÚí ¸ÉÄ¡õ 
ÒÇ¢Â¢¨Ä¨Â ¿ýÈ¡öô Ò¸ø”. 
-«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS: 
Polyphenols, Flavanoids 
Ref: www.ncbi.nlm.nih.gov  
ACTIONS: 
 Stimulant, Antifungal and Antiseptic effects  Antibacterial, Antioxidant 
                      Ref: http://www.stuartxchange.org/Sampalok.html 
ÅºõÒ 
BOTANICAL NAME  : Acorus calamus 
ENGLISH NAME      : Sweet flag   
FAMILY                : Araceae 
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ORGANOLEPTIC CHARACTER: 
Suvai   : Kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
¦À¡ÐÌ½õ: 
“À¡õÀ¡¾¢ ¿ïºü Ò¾ôôÒñ ÅÄ¢Å¢¼À¡¸í ÌýÁõ 
ÝõÀ¡ Ã¢Ãò¾À¢ò ¾õÓ¸ ¿¡üÈõÅý Ý¨ÄºýÉ¢ 
Å£õÀ¡õ¨À ¸¡ºõ À¢Ä£¸ï º¢Ä¢À¾õ Å£È¢ÕÁø 
¾¡õÀ¡í ¸¢ÕÁ¢ Â¢¨Å§ÂÌ Á¡º¢Å ºõÀ¢¨É§Â” 
-§¾¨ÃÂ÷ Ì½Å¡¸¼õ   
CHEMICAL CONSTITUENTS: 
  Asarone, Calamenol, Calamene, Eugenol, Methyl Eugenol, Pinene, 
Camphene, Calamol, Azulene  
                                        Ref:Database Vol – I, P - 471 
ACTIONS: 
Stimulant 
Stomachic 
Antiperiodic 
Carminative 
Nauseant 
Emetic 
Disinfectant 
Germicide                                           Ref:Database Vol – I, P – 471 
¸¡÷§À¡¸¢ 
BOTANICAL NAME  : Psoralea corylifolia (Linn) 
FAMILY               :  Fabaceae 
ORGANOLEPTIC CHARACTERS :  
  Suvai    :  Kaippu  
  Thanmai   :  Veppam 
 Pirivu   :  Kaarppu 
¦À¡ÐìÌ½õ: 
“¸¡÷§À¡¸  Á¡ÁÃ¢º¢  ¸ñ¼¡ü  ¸ÃôÀ¡ýÒñ 
À£÷ºÌÅ  ¿ïº¢¨Å§À¡õ  À¢ò¾Óñ¼¡õ - À¡÷Á£¾¢ø 
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Å¡¾  ¸À¿¨Áîºø  Åý¦º¡È¢º¢  ÃíÌÁÚï 
º£¾  ÁÄ÷ìÌÆÄ¡ö  ¦ºôÒ” 
-   «¸ò¾¢Â÷Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS: 
Corlifolinin,Corylifolin,Limonene,Isonerbavachalcone,Psorlidin-2’,3’-oxide diacetate  
Isoflavone, Corylinin , along with six known compounds, Isopsoralen , Psoralen ,  
Sophoracoumestan, Neobavaisoflavone , Daidzin and Uracil  
Ref: http://www.ncbi.nlm.nih.gov/pubmed/17365188 
ACTION: 
 Vasodilator activity  
 Laxative 
             Stimulant 
 Anti-staphylococcal activity 
Ref:journ.pharmacetical society of japan[1989,109(12),926-31] 
 
¬Î¾£ñ¼¡ôÀ¡¨Ç 
BOTANICAL NAME  :  Aristolochia bracteolata(lam) 
ENGLISH NAME              : Worm-killer 
FAMILY                :  Aristolochiaceae 
ORGANOLEPTIC CHARACTERS : 
 Suvai      : Kaippu  
  Thanmai   : Veppam 
  Pirivu   : Kaarppu 
¦À¡ÐìÌ½õ: 
“¸¢Ãó¾¢¸Ãô  Àý¦Åì¨¸  §¸º¿Ä¢  Á¡ó¨¾ 
ÂÃó¨¾  Å¢¨É¨Â  ÂÚìÌõ - ÐÈóÐ 
À¢Ã¢¦Â¡½¡  §¿¡ö¸¨ÇÔõ  À¢ýÓýÀ¡  Ã¡Áø 
ÁÈ¢Ô½¡  ãÄ¢Â¢¨¼  Å¡ö” 
- «¸ò¾¢Â÷Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS: 
Naphthoquinone, Aristolindiquinone and Magnoflorine, Aristolic acid (4), and 
the cis- and trans-p-coumaric acids. 
                                     Ref: http://www.ncbi.nlm.nih.gov/pubmed/6539809 
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ACTIONS : 
· Antihelmenthic 
· Emmenagogue 
· Purgative 
· Alterative 
· Antiperiodic 
¿ø¦Äñ¦½ö 
BOTANICAL NAME : Sesamum indicum 
ENGLISH NAME  : Gingelly oil plant 
ORGANOLEPTIC CHARACTER: 
Suvai   : Inippu 
Thanmai  : Veppam 
Pirivu   : Inippu 
¦À¡ÐìÌ½õ: 
“Òò¾¢¿ÂÉì ÌÇ¢÷îº¢ âÃ¢ôÒ ¦ÁöôÒÇ¸ï 
ºòÐÅí ¸ó¾¢ ¾É¢Â¢Ç¨Á- ¦Áò¾×ñ¼¡í 
¸ñ§½¡ö ¦ºÅ¢§¿¡ö ¸À¡ÄÅÆø ¸¡º§¿¡ö 
Òñ§½¡ö§À¡ ¦Áñ¦½öÂ¡ü §À¡üÚ”. 
-«¸ò¾¢Â÷Ì½Å¡¸¼õ       
CHEMICAL CONSTITUENTS: 
Oleic and Linoleic Acid,Calcium, Phosphorus, Sodium Chloride, Lysine, Methionine, 
Free Fatty Acid, Oxalate and Aflatoxin B1 
Ref:http://www.indianjournals.com/ijor.aspx?target=ijor:anft&volume=8
&issue=2&article=003 
ACTIONS: 
Demulcent 
Laxative 
Nutritive 
Emollient 
    Ref:Indian Medicinal plants Compendium, Vol – V,P - 104 
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MATERIALS AND METHODS 
STUDY DESIGN: 
    A Pilot clinical trial 
STUDY PLACE:  
Ayothidoss  Pandithar  Hospital,  
National Institute of Siddha,  
Tambaram Sanatorium, Chennai-47. 
STUDY PERIOD:  
12 months 
SAMPLE: 
Patients reporting at Ayothidoss Pandithar Hospital of National Institute of Siddha.  
SAMPLE SIZE:     
40 patients (20 OP + 20 IP). Out of these 40 Patients, 10 IP patients were given 
Yogam treatment along with trial medicine.  
TRIAL DRUG (INTERNAL): 
 Kukkilaathi chooranam 
Ref:  Sarabaendhira Vaidhya Muraigal -Virana karappan roga sikichai(Pg no.264) 
Dose:  1.5gm, bd  with water. 
Duration:  48 days 
TRIAL DRUG (EXTERNAL): 
 Karappan mel poosu thylam 
Ref:  Vaidhya sinthamani- Sikicha Rathna Deepam-Page no.205 
DRUG STORAGE: 
The trial drug Kukkilaathi Chooranam was stored in clean and dry glass bottles and 
Karappan Mel Poosu Thylam was stored in clean and dry narrow mouthed bottles. 
DISPENSING: 
The Chooranam was given in packets. Oil was given in pet bottles.  
ETHICAL CLEARANCE:  
  After the trial drugs were chosen, they were scrutinized by the Institutional Ethical 
Committee for ethical clearance. 
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YOGAM TECHNIQUES ADVISED ARE: 
· Meditative postures 
o Padmasanam / Sukaasanam. 
· Pranayamam (Omkara Pranayamam, Nithirai Pranayamam). 
· Poorana shanthi aasanam. 
SUBJECT SELECTION: 
         Patients reporting with symptoms of inclusion criteria were subjected to screening test 
and documented using screening proforma. 
 INCLUSION CRITERIA: 
· Age: 20 – 60 years 
· Sex: Both male and female 
· Itching 
· Oozing 
· Erythema 
· Papules & Vesicles 
· Scaling 
· Hyperpigmentation 
· Willing to give specimen of blood for investigation when required. 
· Willing for admission and study in IPD for 48 days or willing to attend OPD 
EXCLUSION CRITERIA: 
· Diabetes mellitus 
· Hypertension and other Cardiac ailments 
· Narcotic addicts 
· Pregnancy and Lactation 
· Evidence of any skin disease other than eczema and Varicose eczema. 
WITHDRAWAL CRITERIA: 
· Intolerance to the drug and development of adverse drug reactions during drug 
trial. 
· Poor patient compliance and defaulters. 
· Patient turning unwilling to continue in the course of clinical trial. 
· Any drastic changes occurring in haematological finding during treatment period. 
· Increase in severity of symptoms. 
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TESTS AND ASSESSMENTS: 
A. Clinical assessment 
B.   Siddha system of examination 
C. Laboratory investigations 
A. CLINICAL ASSESSMENT: 
· Itching 
· Erythematous lesions with oedema 
· Presence of macule /   Papule /  vesicle / pustule 
· Oozing , scaling, lichenification of skin 
· Hyper / hypo / depigmentation     
· Appearance of new lesions 
· Size of the lesions 
B.  SIDDHA SYSTEM OF EXAMINATION- EN VAGAI THERVUGAL: 
1. Naadi. 
2. Sparisam  
3. Naa  
4. Niram  
5. Mozhi  
6. Vizhi  
7. Malam 
8. Moothiram –       Neerkkuri 
Neikkuri 
C. LABORATORY INVESTIGATIONS:  
BLOOD: 
Hb, Total WBC Count 
DC - Polymorphs 
          Lymphocytes  
          Eosinophils  
          Monocytes  
          Basophils  
Total RBC count  
ESR 
Blood sugar-(F)                   (PP) 
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RENAL FUNCTION TESTS: 
             Urea 
             Creatinine 
             Uric acid 
 LIVER FUNCTION TESTS: 
              Serum total bilirubin 
              Direct bilirubin 
              Indirect bilirubin 
              Serum Alkaline phosphatase 
              SGOT 
              SGPT 
   LIPID PROFILE: 
   HDL 
   LDL           
   VLDL  
   Total Cholesterol  
   TGL  
URINE: 
        Albumin 
            Urine sugar- (F)                   (PP) 
        Deposits 
MOTION: 
         Ova  
       Cyst 
DATA COLLECTION FORMS: 
FORM l            : Screening Proforma  
FORM lI   : History taking Proforma  
FORM llI      : Clinical Assessment Proforma 
FORM lV    : Clinical assessment during & after Trial 
FORM V     : Laboratory Investigation Proforma 
FORM VI     : Informed Consent Form 
FORM VII     : Withdrawal Form 
FORM VIII     : Patient Information Sheet 
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STUDY ENROLLMENT  
Patients reporting at the OPD with the clinical symptoms of Karappan were examined 
clinically for enrolling in the study based on the inclusion and exclusion criteria.  
The patients who were enrolled were informed (Form VI) about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms understandable 
to them and the informed consent were obtained in writing from them in the consent form 
(Form VI).  
All these patients were given unique registration card in which the patient’s 
Registration number of the study, Address, Phone number and Doctor’s phone number etc. 
were given, so as to report easily should any complications arise. 
Complete clinical history, complaints, duration, examination findings and laboratory 
investigations were recorded in the prescribed Proforma. Screening Form- I was filled up: 
Form –II and Form –III were used for recording the patient’s history, clinical examination of 
symptoms, signs and laboratory investigations respectively. Patients were advised to take the 
trial drug and appropriate dietary advice was given according to the patient’s perfect 
understanding. 
CONDUCT OF THE STUDY: 
  Purgation with Agasthiyar Kuzhambu – 130 mg at early morning in empty stomach 
with Sangangkuppi juice were given for balancing the deranged Uyir thathu on the first day 
of the treatment.  
 From the next day onwards, the trial drugs Kukkilaathi Chooranam were internally 
given continuously for 48 days and Karappan Mel Poosu Thylam were applied externally for 
48 days. OPD patients were advised to visit the hospital once in 7 days for 48 days. At each 
clinical visit, clinical assessment done and prognosis was noted. For 10 IP patients, the drug 
was given for 48 days along with Yogam. Clinical assessment was done daily for IPD 
patients. Siddha investigations like Neerkkuri and Neikkuri were done and it was recorded in 
the proforma, photographs of Neerkkuri and Neikkuri was taken on the first and the 48th day. 
 Laboratory investigations were done on the first and the 48th day of the trial. After the 
trial period, the patients were advised to visit the OPD for follow-up for further two months 
to observe any recurrence. Defaulters were not allowed to continue the trial was withdrawn 
from the study.  
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DATA ANALYSIS: 
 After enrolling the patient in the study, a separate file was maintained for each and 
every patient and all forms and other information were kept in the file. The screening forms 
were filed separately. The data entry was monitored by the Head of the department and 
faculty members of dept. of Sirappu Maruthuvam. All collected datas were statistically 
analysed by Sr. Research Officer (Statistics) for logical errors and incompleteness of data to 
avoid any bias. No modification in the results was permitted for unbiased reports. Then final 
report was generated. 
OUTCOME: 
 The outcome was mainly assessed by reduction in symptoms like itching, oozing etc. 
Improvement assessed by following assessments. 
 PRIMARY OUTCOME: 
Grade I - Turned to normal skin (good). 
Grade II  - Reduction of Hyper pigmentation (moderate).. 
Grade III        -Reduction of itching, oozing and edema (mild).. 
Grade IV        - Remains the same (no further lesions formed). 
Grade V - New lesions appearing. 
SECONDARY OUTCOME:  
 The effect of Drugs + Yogam 
Grade I - Turned to normal skin (good). 
Grade II - Reduction of Hyperpigmentation (moderate). 
Grade III  -Reduction of itching, oozing and edema (mild). 
Grade IV        - Remains the same (no further lesions formed). 
Grade V - New lesions appearing. 
ADVERSE EFFECT/SERIOUS ADVERSE EFFECT MANAGEMENT:  
 If the trial patient develops any adverse reactions, he/she would be immediately 
withdrawn from the trial and proper management was given in OPD of National Institute of 
Siddha. 
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ETHICAL ISSUES: 
1. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab equipments 
were used.      
2. No other external or internal medicines were used other than the trial drug, for 
treating Varatchi Karappan. There was no infringement on the rights of patient.    
3. The data collected from the patient were kept confidential. The patient was informed 
about the diagnosis, treatment and follow-up.  
4. After the consent of the patient (through consent form) they were enrolled in the 
study.  
5. Informed consent was obtained from the patient explaining to him/her in the language 
understandable to the patient. 
6. Treatment was provided free of cost.  
7. In case of any serious adverse reactions, the patients were given alternative treatment 
at the National Institute of Siddha. 
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OBSERVATION AND RESULTS 
 
The observation and results have been tabulated under the following headings. 
1. Sex distribution 
2. Age distribution 
3. Kaalam distribution 
4. Occupational status 
5. Family History 
6. Diet habits 
7. Paruvakaalam 
8. Thinai  
9. Yakkai Ilakkanam (Physical Constitution) 
10. Gunam  
11. Duration of illness 
12. Clinical features 
13. Site of lesion 
14. Distribution of mukkutram 
15. Udar Kattugal  
16. En Vagai  thervugal 
17. Neerkkuri, Neikkuri  
18. Results after Treatment 
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1. SEX DISTRIBUTION 
 
 
Sl No Sex No of Cases Percentage 
1 Male 22 55% 
2 Female 18 45% 
 
 
Observation 
 
Among the 40 patients (20 OP+20 IP) selected for this study, 55% were males and 
45% females. 
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2. AGE DISTRIBUTION 
 
 
Sl. No Age No of Cases Percentage 
1 20-30 3 7.5% 
2 31-40 7 17.5% 
3 41-50 14 35% 
4 51-60 16 40% 
AGE DISTRIBUTION 
 
Observation 
  Among the 40 patients selected for this study, maximum numbers of patients 40% 
were in the age group of 51 to 60, 35% were in the age group of 41 to 50, 17.5% were in the 
age 31 to 40 and 7.5%  were in the age of 20 to 30. 
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3. KAALAM DISTRIBUTION (According to Age) 
 
In Siddha literature human life has been divided into three periods as follows 
1 Vaatham 
2 Pitham 
3 Kabam 
The duration of each period is said to be 33 years 
Sl No Kaalam No of Cases Percentage 
1 Vatha Kaalam (1-33 Years) 4 10% 
2 Pitha  Kaalam (34-66 years) 36 90% 
3 Kaba Kaalam (67-100 years) 0 0% 
 
KAALAM DISTRIBUTION 
  
Observation 
 
Out of 40 patients, 36 patients were reported in Pitha kaalam, the remaining 4 in 
Vatha kaalam and no patients in kaba kaalam. 
 
71 
 
4. OCCUPATIONAL STATUS 
 
Sl. No Nature of Work No. of Cases Percentage 
1 Home Maker 12 30 % 
2 Coolie 9 22.5% 
3 Business 4 10.00 % 
4 Employee 3 07.50 % 
5 Tailor 2 5% 
6 Electrician 2 05.00 % 
7 Security 2 5 % 
8 Teacher 1 2.5 % 
9 Student 1 2.50 % 
10 Farmer 1 2.5% 
11 Actor 1 02.50 % 
12 Nurse 1 2.5% 
13 Painter 1 2.5% 
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Observation 
 
               The majority of patients in this study were home makers. 
 
5. FAMILY HISTORY 
Sl. No 
 
Criteria 
 
No of Cases Percentage 
1 
 
Family History (+ve) 
 
1 2.5% 
2 
 
Family History (-ve) 
 
39 97.5% 
 
 
 
 
 
Observation 
 Among 40 patients (20 IP + 20 OP), 97.5% of the patients showed no family history, 
2.5% showed positive family history. 
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6.  DIETARY HABITS 
 
 
Sl. No Dietary Habits No of Cases Percentage 
1 Vegetarian 2 5% 
2 Non Vegetarian 38 95% 
 
 
 
 
 
 
Observation 
 
All the cases except two were non-vegetarians. 
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7. PARUVA KAALAM 
 
Sl 
No. 
Paruva Kaalam No. of Cases Percentage 
1 Kaar kaalam (Aavani & Purattasi) 20 50% 
2 Koothir Kaalam (Aippasi&Kaarthigai) 4 10% 
3 Munpani Kaalam (Margazhi& Thai) 0 0 
4 Pinpani Kaalam (Maasi&Panguni) 0 0 
5 Elavenil Kaalam (Chithirai & Vaikasi) 0 0 
6 Muthuvenil Kaalam (Aani&Aadi) 16 40% 
 
 
 
 
Observation 
Among the 40 patients admitted for this study, the highest number of patients(50%) 
reported in Kaar Kaalam, 40% are reported in muthuvenil kaalam and 10% are reported in 
kootthir kaalam. 
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8. THINAI REFERENCE 
 
Sl. No Thinai No. of Cases Percentage 
1 Kurinji (Hill Area) 0 0 
2 Mullai (Forest Area) 0 0 
3 Marutham (Fertile Land) 10 25% 
4 Neithal (Coastal Area) 30 75% 
5 Palai (Desert Land) 0 0 
 
 
 
 
 
Observation 
 
Among the 40 patients, 75% of the patients were from Neithal (Coastal Area) and the 
remaining 25% are from Marutham (Fertile Land). 
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9. YAAKAI ILAKKANAM 
 
Sl. No Yaakai Ilakkanam No. of Cases Percentage 
1 VathaUdal 0 0.00% 
2 PithaUdal 0 0.00% 
3 KabaUdal 0 0.00% 
4 ThonthaUdal 40 100.00% 
 
 
 
 
Observation 
 
All the 40 patients (100%) had Thontha Udal 
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10. GUNAM (QUALITY AND CHARACTERS) 
 
Sl. No Gunam No of Cases Percentage 
1 Satthuva Gunam 0 0% 
2 Raso Gunam 40 100% 
3 Thamo Gunam 0 0% 
 
 
 
 
Observation 
 
All the 40 patients had RajoGunam  
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12. DURATION OF ILLNESS 
 
 
Sl. No Duration of Illness No of Cases Percentage 
1 > 1 Year 7 17.50 % 
2 1-5 Years 27 67.50 % 
3 6-10 Years 6 15 % 
4 11-15 Years 0 0 % 
5 16-20 Years 0 0 % 
 
 
 
 
 
Observation:   
 
Among the 40 patients the maximum number of patients (67.5%) have the duration of  
illness between 1-5 years. 
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13. CLINICAL FEATURES 
 
Sl. No Clinical Features No of Cases Percentage 
1 Itching 40 100% 
2 Vesicle formation 12 30% 
3 Oozing 40 100% 
4 Papules 8 20% 
5 Scaling 21 52.5% 
6 Erythema 5 12.5% 
7 Hyperpigmentation 40 100% 
8 Hypopigmentation 5 12.5% 
9 Lichenification 24 60% 
 
CLINICAL FEATURES 
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Observation: All the patients selected for the study have itching,oozing and 
hyperpigmentation, 52.5% of them had scaling,60% of them had lichenification,30% of them 
had vesicles,20% of them had papules,12.5% of them had erythema and hypopigmentation. 
14. SITE OF LESION 
Sl. 
No 
               Site of Lesion         No of Cases          Percentage 
   1  Both Upper Limb               2            5% 
   2  Both  Lower Limb              21            52.5% 
   3  Upper limb & Lower limb               12              30% 
   4  Left lower limb               3             7.5% 
   5 Right lower limb               2             5% 
  
 
Observation 
         Among 40 patients , 5% had the lesion in both upperlimb, 52.5% had the lesion in  both 
lower limb, 30% had the lesion both in upper limb and in lower limb and 5% had right lower 
limb,7.5% had left lower limb. 
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15.DISTRIBUTION OF UYIRTHATHUKKAL: 
The derangement of Vaatham, Pitham and Kabam in Karappan is as follows 
VAATHAM 
 
Sl. No Classification of Vaatham No of Cases Percentage 
1 Praanan 0 0.00% 
2 Abaanan 6 25% 
3 Udhaanan 0 0.00% 
4 Samaanan 40 100.00% 
5 Viyaanan 40 100.00% 
6 Naagan 0 0.00% 
7 Koorman 0 0.00% 
8 Kirukaran 4 10% 
9 Devathathan 8 20% 
10 Dananjayan 0 0.00% 
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Observation :  Samanan and Viyanan was found to be affected in all the 40 patients and 
devathathan was affected in 20% of patients, kirukaran was affected in 10% of patients, 
Abanan was affected in 15%  of  patients. 
PITHAM 
 
Sl. 
No 
Classification of Pitham No. of Cases Percentage 
1 Akkanal (Anarpitham) 4 10% 
2 Vanna Eri (Ranjakam) 0 0.00% 
3 Atralangi (Sathakam) 0 0.00% 
4 Nokkanal (Alosakam) 0 0.00% 
5  Ullolli thee (Prasakam) 40 100.00% 
 
 
Observation 
 
Prasakam was affected in all the cases. Anarpitham was found affected in 10 % of the 
patients.  
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KABAM 
 
 
Sl. No Classification of Kabam No of Cases Percentage 
1 Avalambagam 0 0.00% 
2 Kilethagam 4 10% 
3 Pothagam 0 0.00% 
4 Tharpagam 0 0.00% 
5 Santhigam 7 17.5.% 
 
 
 
 Observation : 
 
In 10 % of the patients, Kilethagam was found to be affected. Santhigam was affected 
in 17.5% of the patients. 
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16. UDAL KATTUKAL 
 
Sl. No UdarKattugal No of Cases Percentage 
1 Saaram 40 100% 
2 Senneer 40 100% 
3 Oon 0 0% 
4 Kozhuppu 0 0% 
5 Enbu 0 0% 
6 Moolai 0 0% 
7 Sukkilam/Suronitham 0 0 % 
 
 
 
 
Observation: 
Among 40 patients, Saaram , Senneer were affected in all the cases. 
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17. EN VAGAI THERVUKAL 
 
Sl. 
No En VagaiThervukal No. of Cases Percentage 
1 Naa 0 0.00% 
2 Niram 40 100.00% 
3 Mozhi 0 0.00% 
4 Vizhi 0 0.00% 
5 Sparisam 40 100.00% 
6 Malam 0 0.00% 
7 Moothiram 0 0.00% 
8 Naadi   
 a. Vathapitham 35 87.5% 
 b. Pithavatham 5 12.5% 
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Observation: 
In Envagai thervukal, Niram and Sparisam were found to be affected in all the 40 
cases. The Naadinadai seen in Varatchi Karappan patients were Vathapitham 87.5 %, 
Pithavatham 12.5 %. 
 
18. NEERKKURI, NEIKKURI REFERENCE  
 
Sl. 
No Type of Test No. of Cases Percentage 
1 
Neerkkuri: 
- straw yellow 
40 100% 
2 
Neikkuri: 
          Pitham-  
 
Kabam   
 
 
22 
 
18 
         
 
            55% 
 
            45% 
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OP CASES 
 
Sl 
No OP No Name 
Age / 
Sex DOA DOI DOD 
No of 
Days 
Treated 
Result 
1 C87535 Mrs.U.Karpagaselvi 34/F 4.9.12 6 Mon 23.10.12 48 GRADE II 
2 C85998 Mr.J.Gopala Krishnan 60/M 17.9.12 3 Yrs 5.11.12 48 GRADE II 
3 C91000 Mrs.S.Shanthi 50/F 7.9.12 2 Yrs 26.10.12 48 GRADE II 
4   A86946 Mr.B.Ariyankavoo 52/M 30.7.12 2 Yrs 17.9.12 48 GRADE II 
5 C88973 Mr.T.Shankar 57/M 16.8.12 2 Yrs 4.10.12 48 GRADE II 
6 C74451 Mr.G.John Kennady 38/M 7.8.12 5 Yrs 25.9.12 48 GRADE III 
7 C39079 Mr.T.Deva Raj 55/M 4.7.12 5 Yrs 22.8.12 48 GRADE II 
8 C90870 Mrs.S.Tamilarasi 52/F 20.8.12 5 Yrs 8.10.12 48 GRADE III 
9 C83380 Miss.N.Sangeetha 20/F 4.8.12 5 Yrs 22.9.12 48 GRADE II 
10 C90868 Mrs.A.Kadhija Begam  30/F 25.8.12 10 Yrs 13.10.12 48 GRADE II 
11 C87724 Mr.V.Thiruthuvanathan 46/M 16.8.12 6 Mon 4.10.12 48 GRADE II 
12 AC8305 Mr.Mohamed Iqbal 48/M 2.8.12 1 Mon 20.9.12 48 GRADE II 
13 A28604 Mrs.Karpagam 34/F 23.7.12 6 Yrs 10.9.12 48 GRADE II 
14 C83076 Mr.K.Yogeshwaran 48/M 21.7.12 6 Yrs 8.9.12 48 GRADE II 
15 C91261 Mr.J.Saravanan 38/M 18.8.12 5 Yrs 6.10.12 48 GRADE III 
16 C76751 Mr.G.Meiazhagar 51/M 18.8.12 1.5 Yrs 6.10.12 48 GRADE III 
17 C85591 Mr.K.Venkatachalam 30/M 25.7.12 1 Yrs 12.9.12 48 GRADE IV 
18 C86010 Mr.Parthiban 22/M 26.7.12 1 Yrs 13.9.12 48 GRADE IV 
19 C90770 Mrs.S.Rani 44/F 16.8.12 4 Yrs 4.10.12 48 GRADE II 
20 C74448 Mr.S.R.Krishnamoorthy 55/M 21.7.12 3 Yrs 8.9.12 48 GRADE III
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IP CASES 
Sl 
No 
IP 
No Name 
Age/ 
Sex DOA DOI DOD 
No of 
Days 
Treated 
Result 
1 5060 Mr.Chelladurai 60/M 24.8.12 1yrs 19.10.12 48 GRADE II 
2 4108 Mrs.Mageshwari 56/F 24.8.12 3yrs 12.10.12 48 GRADE III 
3 5099 Mr.G.Kannan 38/M 4.9.12 3 Mon 23.10.12 48 GRADE II 
4 5119 Mr.A.Anwar Hussain 55/M 11.9.12 6 Yrs 30.10.12 48 GRADE II 
5 554 Mrs.R.Sivagami 29/F 24.9.12 1 Yrs 12.11.12 48 GRADE II 
6 4154 Mrs.P.Padmavathi 48/F 5.9.12 2 Yrs 24.10.12 48 GRADE II 
7 5142 Mr.M.JayaKumar 47/M 17.9.12 3 Mon 28.10.12 48 GRADE III 
8 4961 Mr.M.HariKrishnan 55/M 24.07.12 6 Mon 11.12.12 48 GRADE II 
9 5036 Mr.Rajendren 44/M 17.8.12 2 Yrs   5.10.12 48 GRADE II 
10 4270 Mrs.P.Jayagandhi 45/F 13.10.12 2 Mon 1.12.12 48 GRADE II 
11 4256 Mrs.K.Angammal 48/F 09.10.12 1 Yrs 27.11.12 48 GRADE II 
12 4281 Mrs.A.Krishnaveni 51/F 22.10.12 2 Yrs 10.12.12 48 GRADE III 
13 4282 Mrs.S.Savithri 46/F 23.10.12 2 Yrs 11.12.12 48 GRADE III 
14 4135 Mrs.Jayalakshmi 47/F 29.8.12 8 Yrs 24.10.12 48 GRADE III 
15 3981 Mrs.Sowndari 50/F 20.7.12 1 Yrs   14.9.12 48 GRADE II 
16 3992 Mrs.Sundari 60/F 23.7.12 5 Yrs   10.9.12 48 GRADE III 
17 4073 Mrs.Nirmala 42/F 13.8.12 3 Yrs    8.8.12 48 GRADE III 
18 5030 Mr.SivaKumar 41/M 15.8.12 10 Yrs   3.10.12 48 GRADE II 
19 5098 Mr.Mani 60/M 3.9.12 2 Yrs 22.10.12 48 GRADE II 
20 5186 Mr.Ganesan 46/M 16.8.12 3 Yrs 4.10.12 48 GRADE IV 
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19.RESULTS 
 
 
 
Observation: 
        Among the 40 patients, 62.5% shown moderate improvement, 30% shown mild 
improvement and 7.5% shown no improvement.  
 
 
Sl. No Results No of Cases Percentage 
1 GRADE I - Turned to normal skin (good). - - 
2 GRADE II -  Reduction of Hyper pigmentation (moderate) 25 62.5% 
3 
GRADE III -  Reduction of itching, oozing and 
edema (mild). 12 30% 
4 
GRADE IV -  Remains the same (no further lesions 
formed). 3 7.5% 
5 
 GRADE V -  New lesions appearing. - - 
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IP CASES  TRIAL DRUG ALONG WITH YOGAM  
 
DISCUSSION: 
Hence Yogam treatment along with the trial drugs is effective in the treatment of 
Varatchi Karappan when compared to the treatment with the trial drugs alone. 
RESULT: 
Yogam treatment proved to be effective in reducing the Stress, Sleeplessness and 
Clinical Symptoms of Varatchi Karappan in this clinical trial. 
 
 
 IP No Name Age/ Sex Result 
1 5060 Mr.Chelladurai 60/M GRADE II 
2 3992 Mrs.Sundari 60/F GRADE III 
3 5099 Mr.G.Kannan 38/M GRADE II 
4 5119 Mr.A.Anwar Hussain 55/M GRADE II 
5 554 Mrs.R.Sivagami 29/F GRADE II 
6 4154 Mrs.P.Padmavathi 48/F GRADE II 
7 5186 Mr.Ganesan 46/M GRADE IV 
8 4073 Mrs.Nirmala 42/F GRADE III 
9 4135 Mrs.Jayalakshmi 47/F GRADE III 
10 3981 Mrs.Sowndari 50/F GRADE II 
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IP CASES  TRIAL DRUG ALONG WITH YOGAM 
 
 
Observation: 
        Among the 10 patients, 60% shown moderate improvement, 30% shown mild 
improvement and 10% showed no improvement.  
 
Sl. No Results No of Cases Percentage 
1 GRADE I- Turned to normal skin (good). - - 
2 GRADE II-  Reduction of Hyper pigmentation (moderate) 6 60% 
3 GRADE III-  Reduction of itching, oozing and edema (mild). 3 30% 
4 GRADE IV-  Remains the same (no further lesions formed). 1 10% 
5 GRADE V-  New lesions appearing. - - 
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OUT-PATIENT’S BLOOD INVESTIGATION CHART 
 
Sl.no Op .no Name 
Hb 
gm% 
TC 
Cells/ 
Cumm 
RBC 
million 
Cells/ 
cu.mm 
ESR/hr 
BT AT BT AT BT AT BT AT 
1 C87535 Mrs.U.Karpagaselvi 12.2 10.1 9400 8000 4.1 4 32 6 
2 C85998 Mr.J.Gopala Krishnan 14.8 13 7300 7000 4.7 4.7 6 14 
3 C91000 Mrs.S.Shanthi 11.5 10.2 7900 11500 4.5 4.6 10 10 
4 A86946 Mr.B.Ariyankavoo 15.8 14.5 12800 6200 5.5 5.2 10 10 
5 C88973 Mr.T.Shankar 15.1 12.5 5800 7800 5.9 5.5 6 20 
6 C74451 Mr.G.John Kennady 14.5 14.9 4600 5000 5.3 4.8 6 14 
7 C39079 Mr.T.Deva Raj 13.2 13.4 8900 6700 4.9 4.8 26 28 
8 C90870 Mrs.S.Tamilarasi 12.3 10.6 6800 5200 4.2 4.3 16 26 
9 C83380 Miss.N.Sangeetha 13.5 13.6 6700 5300 4.5 4.6 4 12 
10 C90868 Mrs.A.Kadhija Begam  11.1 8.9 5600 5100 4.1 4 8 10 
11 C87724 Mr.V.Thiruthuvanathan 16.4 14.3 7500 8400 5.4 5.4 4 4 
12 AC8305 Mr.Mohamed Iqbal 12.4 15.3 8500 10100 5.1 5 6 10 
13 A28604 Mrs.Karpagam 14.1 12.1 7000 6800 5.1 4.2 24 16 
14 C83076 Mr.K.Yogeshwaran 15.5 15.3 7300 6900 5.2 5.1 6 4 
15 C91261 Mr.J.Saravanan 15.6 13.8 8400 7700 5.2 5.3 4 4 
16 C76751 Mr.G.Meiazhagar 13.6 11.5 7000 6500 4.7 4.4 12 8 
17 C85591 Mr.K.Venkatachalam 15.3 14.6 9,400 8,700 4.8 4.5 22 10 
18 C86010 Mr.Parthiban 15.1 14.7 8400 5700 5.3 4.6 10 6 
19 C90770 Mrs.S.Rani 13.5 13.7 5300 5700 4.9 5.3 8 4 
20 C74448 Mr.S.R.Krishnamoorthy 14.1 14.7 4400 5700 4.9 5.1 8 16 
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OUT-PATIENT’S   BLOOD   INVESTIGATION   CHART 
 
Sl.
no 
Op .no 
Poly 
morphs 
Lympho
cytes 
Mono 
cytes 
Eosino 
phils 
Basophils Blood 
Sugar(F) 
Blood sugar 
(PP) 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 C87535 65 63 30 32     5 5   
 
91 103 105 118 
2 C85998 50 50 45 44     5 6   
 
108 106 124 121 
3 C91000 62 60 33 35 5 5       
 
106 95 118 108 
4 A86946 61 58 29 37 1   9 5   
 
87 101 139 123 
5 C88973 62 72 33 24     5 4   
 
104 118 107 123 
6 C74451 60 64 33 30 2   5 6   
 
87 101 101 120 
7 C39079 38 54 39 35     22 11 1 
 
71 87 93 116 
8 C90870 64 62 33 33     3 5   
 
96 119 116 131 
9 C83380 55 45 42 50     3 5   
 
85 92 118 111 
10 C90868 54 60 38 36 2 6 4     
 
103 105 117 124 
11 C87724 65 65 31 30     4 5   
 
99 99 106 122 
12 AC8305 68 60 24 34 1   7 6   
 
104 104 145 125 
13 A28604 61 65 34 30     5 5   
 
99 92 112 111 
14 C83076 46 33 45 59 2 1 7 7   
 
104 88 116 125 
15 C91261 60 65 33 28     7 7   
 
101 99 111 120 
16 C76751 63 64 32 33     5 3   
 
90 118 148 142 
17 C85591 53 65 23 33 1   3 2   
 
92 98 101 123 
18 C86010 53 58 40 35   5 7 2   
 
80 92 96 107 
19 C90770 50 63 42 30 1   7 7   
 
103 98 117 108 
20 C74448 59 63 34 31 2   5 6   
 
83 94 112 127 
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OUT-PATIENT’S   RENAL FUNCTION TEST CHART 
 
Sl.no Op .no Name 
Urea  
mg/dl 
 
Creatinine  
mg/dl 
 
Uric Acid 
 mg/dl 
BT AT BT AT BT AT 
1 C87535 Mrs.U.Karpagaselvi 18 22 0.6 0.7 2.2 3.9 
2 C85998 Mr.J.Gopala Krishnan 16 19 0.5 0.6 8.8 6.2 
3 C91000 Mrs.S.Shanthi 17 15 0.5 0.5 5 3 
4 A86946 Mr.B.Ariyankavoo 24 19 0.7 0.5 5.2 3.2 
5 C88973 Mr.T.Shankar 14 20 0.4 0.6 5 5 
6 C74451 Mr.G.John Kennady 21 17 0.6 0.6 5.2 4.4 
7 C39079 Mr.T.Deva Raj 20 16 0.6 0.5 4.7 3.2 
8 C90870 Mrs.S.Tamilarasi 18 25 0.5 0.7 5 5.2 
9 C83380 Miss.N.Sangeetha 14 15 0.4 0.5 4.7 3.1 
10 C90868 Mrs.A.Kadhija Begam  18 20 0.9 0.7 4 3 
11 C87724 Mr.V.Thiruthuvanathan 17 20 0.5 0.6 8.2 5.3 
12 AC8305 Mr.Mohamed Iqbal 28 15 0.8 0.6 5 3.7 
13 A28604 Mrs.Karpagam 16 21 0.5 0.6 3.3 3.1 
14 C83076 Mr.K.Yogeshwaran 17 19 0.6 0.5 5.7 4.7 
15 C91261 Mr.J.Saravanan 33 29 0.8 0.8 6 5.4 
16 C76751 Mr.G.Meiazhagar 20 17 0.6 0.5 7.4 5 
17 C85591 Mr.K.Venkatachalam 20 18 0.6 0.5 5 4 
18 C86010 Mr.Parthiban 17 20 0.5 0.7 5.4 4.1 
19 C90770 Mrs.S.Rani 14 28 0.4 0.7 5.9 4.3 
20 C74448 Mr.S.R.Krishnamoorthy 17 24 0.5 0.6 4.5 5 
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OUT-PATIENT’S  LIVER FUNCTION TEST CHART 
 
Sl.
no 
Op .no 
Total 
Bilirubin 
mg/dl 
 
Direct 
Bilirubin 
mg/dl 
 
Indirect 
Bilirubin 
mg/dl 
 
SGOT 
IU 
SGPT 
   IU 
Alk.phos 
mg/dl 
 
BT AT BT AT BT AT BT AT BT AT BT AT 
1 C87535 0.5 0.5 0.2 0.2 0.3 0.3 20 10 21 11 150 135 
2 C85998 0.8 0.6 0.3 0.2 0.5 0.4 11 18 12 21 178 149 
3 C91000 0.4 0.5 0.2 0.2 0.2 0.3 23 43 25 46 154 231 
4 A86946 0.5 0.7 0.2 0.3 0.3 0.4 26 12 27 15 196 147 
5 C88973 0.5 0.6 0.2 0.2 0.3 0.4 36 20 28 22 175 185 
6 C74451 1 0.4 0.4 0.2 0.6 0.2 17 12 18 13 146 216 
7 C39079 0.5 0.8 0.2 0.3 0.3 0.5 11 16 12 18 145 196 
8 C90870 0.5 0.7 0.2 0.3 0.3 0.4 13 25 15 27 142 191 
9 C83380 0.6 0.7 0.2 0.3 0.4 0.4 29 16 30 18 179 176 
10 C90868 0.5 0.5 0.2 0.2 0.3 0.3 12 13 14 15 155 189 
11 C87724 0.5 0.6 0.2 0.2 0.3 0.4 27 26 30 28 18 187 
12 AC8305 0.7 0.6 0.4 0.2 0.6 0.4 18 19 26 20 215 243 
13 A28604 0.9 1.2 0.5 0.6 0.4 0.6 37 24 32 30 187 170 
14 C83076 0.5 0.6 0.4 0.2 0.7 0.4 28 30 30 32 215 190 
15 C91261 0.5 0.4 0.2 0.2 0.3 0.2 28 10 29 11 271 177 
16 C76751 0.5 0.7 0.2 0.3 0.3 0.4 27 19 28 21 156 183 
17 C85591 0.6 0.5 0.3 0.6 0.5 0.4 24 31 18 25 184 210 
18 C86010 0.5 0.4 0.3 0.3 0.2 0.1 35 27 24 32 187 210 
19 C90770 0.3 0.5 0.2 0.3 0.1 0.2 41 35 51 47 272 187 
20 C74448 0.7 0.6 0.4 0.5 0.3 0.2 27 32 36 33 164 214 
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OUT-PATIENT’S  LIPID PROFILE TEST CHART 
 
Sl.
no 
Op .no Name 
HDL 
(mg/dl) 
LDL 
(mg/dl)           
VLDL 
(mg/dl) 
Total 
Cholesterol
(mg/dl) 
Triglycerides 
(mg/dl) 
BT AT BT AT BT AT BT AT BT AT 
1 C87535 Mrs.U.Karpagaselvi 22 33 88 91 10 12 120 182 50 59 
2 C85998 Mr.J.Gopala Krishnan 25 35 182 96 32 30 182 208 162 150 
3 C91000 Mrs.S.Shanthi 32 36 106 120 47 23 136 243 238 115 
4 A86946 Mr.B.Ariyankavoo 31 36 109 102 30 20 177 160 153 102 
5 C88973 Mr.T.Shankar 40 43 162 117 14 15 195 234 73 76 
6 C74451 Mr.G.John Kennady 33 30 130 74 23 18 181 90 117 90 
7 C39079 Mr.T.Deva Raj 30 34 82 116 17 19 180 176 89 97 
8 C90870 Mrs.S.Tamilarasi 45 45 132 115 27 57 199 187 137 150 
9 C83380 Miss.N.Sangeetha 26 41 78 70 16 14 149 136 84 71 
10 C90868 Mrs.A.Kadhija Begam  35 34 116 82 27 17 170 175 137 86 
11 C87724 Mr.V.Thiruthuvanathan 22 32 82 76 12 16 111 142 60 81 
12 AC8305 Mr.Mohamed Iqbal 29 40 145 86 41 31 193 153 205 157 
13 A28604 Mrs.Karpagam 30 44 102 106 28 19 140 213 140 96 
14 C83076 Mr.K.Yogeshwaran 36 32 96 80 24 21 157 160 121 108 
15 C91261 Mr.J.Saravanan 35 36 152 124 31 30 207 227 158 151 
16 C76751 Mr.G.Meiazhagar 36 31 86 69 14 12 136 132 70 62 
17 C85591 Mr.K.Venkatachalam 29 35 80 110 25 28 149 153 125 117 
18 C86010 Mr.Parthiban 22 31 45 70 17 15 100 93 88 92 
19 C90770 Mrs.S.Rani 44 35 240 184 25 18 215 193 128 116 
20 C74448 Mr.S.R.Krishnamoorthy 31 45 125 117 17 30 173 197 86 90 
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OUT-PATIENT’S URINE INVESTIGATION CHART 
 
Sl.no   op .no            Name 
   Albumin       Sugar                 Deposits 
BT AT BT AT        BT        AT 
 1 C87535 Mrs.U.Karpagaselvi Nil  Nil  Nil  Nil  1-2Pus , 1-2 Epi 1-2Pus , 2-4 Epi 
2 C85998 Mr.J.Gopala Krishnan Nil  Nil  Nil  Nil  2-3Pus, 2-3 Epi 2-4Pus, 2-4 Epi 
3 C91000 Mrs.S.Shanthi Nil  Nil  Nil  Nil  2-3Pus, 1-2 Epi 8-10Pus, 10-15 
Epi 
4 A86946 Mr.B.Ariyankavoo Nil  Nil  Nil  Nil  2-3Pus, 2-3 Epi 2-3Pus, 1-2 Epi 
5 C88973 Mr.T.Shankar Nil  Nil  Nil  Nil  1-2Pus, 1-2 Epi 1-2Pus, 2-4 Epi 
6 C74451 Mr.G.John Kennady Nil  Nil  Nil  Nil  2-4Pus, 2-4 Epi 2-4Pus, 2-4 Epi 
7 C39079 Mr.T.Deva Raj Nil  Nil  Nil  Nil  1-2Pus, 2-3 Epi 1-2Pus, 2-4 Epi 
8 C90870 Mrs.S.Tamilarasi Nil  Nil  Nil  Nil  2-4Pus, 1-2 Epi 1-2Pus, 2-4 Epi 
9 C83380 Miss.N.Sangeetha Nil  Nil  Nil  Nil  2-4Pus, 2-4 Epi 4-5Pus, 3-4 Epi 
10 C90868 Mrs.A.Kadhija Begam  Nil  Nil  Nil  Nil  1-2Pus, 2-3 Epi 2-4Pus, 2-4 Epi 
11 C87724 Mr.V.Thiruthuvanathan Nil  Nil  Nil  Nil  1-2Pus, 1-2 Epi 2-4Pus, 2-4 Epi 
12 AC8305 Mr.Mohamed Iqbal Nil  Nil  Nil  Nil  1-2Pus, 2-3 Epi 1-3Pus, 3-4 Epi 
13 A28604 Mrs.Karpagam Nil  Nil  Nil  Nil  2-6Pus, 2-6 Epi 10-12Pus, Plenty 
of Epi cells 
14 C83076 Mr.K.Yogeshwaran Nil  Nil  Nil  Nil  2-6Pus, 2-6Epi 2-4 Pus, 1-2 Epi 
15 C91261 Mr.J.Saravanan Nil  Nil  Nil  Nil  1-2Pus, 1-2Epi 1-2Pus, 2-4 Epi 
16 C76751 Mr.G.Meiazhagar Nil  Nil  Nil  Nil  1-2Pus, 1-2Epi 2-4 Pus, 2-4 Epi 
17 C85591 Mr.K.Venkatachalam Nil  Nil  Nil  Nil  1-2Pus, 2-4Epi 1-3Pus, 2-4 Epi 
18 C86010 Mr.Parthiban Nil  Nil  Nil  Nil  2-4 Pus, 2-4 Epi  1-2 Pus, 1-2 Epi 
19 C90770 Mrs.S.Rani Nil  Nil  Nil  Nil  1-2 Pus, 1-2 Epi 2-4 Pus, 1-3 Epi 
20 C74448 Mr.S.R.Krishnamoorthy Nil  Nil  Nil  Nil  1-2 Pus, 1-2 Epi 1-3Pus, 2-4 Epi 
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IN-PATIENT’S   BLOOD   INVESTIGATION   CHART 
 
 
Sl.no Ip .no Name 
Hb 
gm% 
TC 
Cells/ 
Cu.mm 
RBC 
million 
Cells/ 
cu.mm 
ESR/hr 
mm 
BT AT BT AT BT AT BT AT 
1 5060 Mr.Chelladurai 12 11.9 5300 4600 4.9 4.5 18 20 
2 4108 Mrs.Mageshwari 14.5 11.7 7100 7200 5 4.8 10 10 
3 5099 Mr.G.Kannan 14.2 13.7 10600 9500 4.7 4.9 8 4 
4 5119 Mr.A.Anwar Hussain 12.5 10.6 9600 6500 4.9 5 26 12 
5 4215 Mrs.R.Sivagami 11.5 10.5 7100 7700 4.4 4.7 70 6 
6 4154 Mrs.P.Padmavathi 11.5 10 7200 6800 4 4.5 94 22 
7 5142 Mr.M.JayaKumar 13.4 12 7900 6300 4.6 4.2 20 8 
8 4961 Mr.M.HariKrishnan 15.6 14.2 11700 9200 4.6 4.2 4 6 
9 5036 Mr.Rajendren 11.2 12 6500 6900 4.2 4 22 8 
10 4270 Mrs.P.Jayagandhi 11.6 10.5 7900 10600 4.3 3.1 18 22 
11 4256 Mrs.K.Angammal 14 11.3 9400 8600 4.8 4.7 8 4 
12 4281 Mrs.A.Krishnaveni 9.3 9.7 8200 6200 4 4.5 12 56 
13 4282 Mrs.S.Savithri 10 9.2 6700 7200 4.3 3.8 10 24 
14 4135 Mrs.Jayalakshmi 11.8 10.5 9900 8800 4.8 4.7 10 4 
15 3981 Mrs.Sowndari 13.8 13.2 9800 9600 4.3 4.2 28 16 
16 3992 Mrs.Sundari 13 13.9 8200 9900 4.2 4.7 20 16 
17 4073 Mrs.Nirmala 12.4 11.1 11400 11000 4.2 4.1 40 52 
18 5030 Mr.SivaKumar 15.4 13 10100 8300 4.7 4.5 22 10 
19 5098 Mr.Mani 14.6 11 7100 5200 5 6 6 12 
20 5186 Mr.Ganesan 11.4 10.5 6000 8100 2.6 2.7 36 8 
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IP-PATIENT’S   BLOOD   INVESTIGATION   CHART 
 
 
 
 
Sl. 
no 
Ip 
.no 
Poly 
morphs 
Lympho
cytes 
Mono 
cytes 
Eosino 
phils 
Basophils Blood 
Sugar(F) 
Blood sugar 
(PP) 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 5060 60 64 33 27     6 9 
  
116 103 127 118 
2 4108 55 55 46 32 4 13     
  
109 116 138 124 
3 5099 49 72 32 23 4   15 5 
  
94 86 109 102 
4 5119 72 59 23 36     5 5 
  
81 94 106 119 
5 4215 70 75 25 32     5 3 
  
76 84 134 103 
6 4154 72 64 24 31 4     5 
  
117 119 132 137 
7 5142 62 74 33 31 5 1   4 
  
91 72 142 118 
8 4961 69 72 25 23 1 5 5   
  
73 78 93 102 
9 5036 62 72 33 24 5 4     
  
82 87 117 123 
10 4270 57 48 32 43     11 9 
  
95 84 108 102 
11 4256 74 71 22 24     4 5 
  
88 98 140 112 
12 4281 74 62 22 32     4 6 
  
91 94 115 110 
13 4282 46 59 42 36   1 12 4 
  
101 86 120 102 
14 4135 67 52 30 41     3 7 
  
87 98 100 139 
15 3981 59 58 37 37     4 5 
  
81 77 98 126 
16 3992 61 68 30 27     9 5 
  
81 96 98 103 
17 4073 55 59 32 36     3 5 
  
104 109 122 118 
18 5030 70 60 24 34 6 6     
  
104 104 121 119 
19 5098 63 50 32 44 5 6     
  
106 94 120 112 
20 5186 60 70 35 27     5 3 
  
119 94 167 142 
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IN-PATIENT’S RENAL FUNCTION TEST CHART 
 
Sl.no 
Ip 
.no 
Name 
Urea  
mg/dl 
 
Creatinine  
mg/dl 
 
Uric Acid 
 mg/dl 
BT AT BT AT BT AT 
1 5060 Mr.Chelladurai 15 16 0.4 0.5 4.8 4.3 
2 4108 Mrs.Mageshwari 14 14 0.4 0.4 5.5 4 
3 5099 Mr.G.Kannan 15 20 0.4 0.6 3.7 3.5 
4 5119 Mr.A.Anwar 
Hussain 
29 17 0.6 0.6 4.3 6.2 
5 4215 Mrs.R.Sivagami 15 14 0.4 0.4 5 3.9 
6 4154 Mrs.P.Padmavathi 33 28 0.9 0.8 5.4 5 
7 5142 Mr.M.JayaKumar 22 28 0.6 0.5 4.7 5 
8 4961 Mr.M.HariKrishnan 14 17 0.5 0.8 5 4.3 
9 5036 Mr.Rajendren 31 25 0.7 0.6 5 4.5 
10 4270 Mrs.P.Jayagandhi 21 18 0.6 0.7 5 3 
11 4256 Mrs.K.Angammal 19 14 0.5 0.5 3.6 3 
12 4281 Mrs.A.Krishnaveni 14 18 0.5 0.6 3 3 
13 4282 Mrs.S.Savithri 15 17 0.5 0.7 4.1 3.2 
14 4135 Mrs.Jayalakshmi 16 19 0.5 0.6 4.2 3 
15 3981 Mrs.Sowndari 20 23 0.7 0.7 6.5 5 
16 3992 Mrs.Sundari 30 43 0.9 1 4.9 4.3 
17 4073 Mrs.Nirmala 14 14 0.4 0.5 4 3.9 
18 5030 Mr.SivaKumar 16 15 0.5 0.5 4.6 5.2 
19 5098 Mr.Mani 17 15 0.5 0.5 6.2 5 
20 5186 Mr.Ganesan 17 17 0.6 0.6 5 4.6 
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IN-PATIENT’S LIVER FUNCTION TEST CHART 
 
Sl.
no 
Ip 
.no 
Name 
Total 
Bilirubin 
mg/dl 
 
Direct 
Bilirubin 
mg/dl 
 
Indirect 
Bilirubin 
mg/dl 
 
SGOT 
IU 
SGPT 
   IU 
Alk.phos 
mg/dl 
 
BT AT BT AT BT AT BT AT BT AT BT AT 
1 5060 Mr.Chelladurai 15 16 0.4 0.2 0.4 0.4 14 17 15 19 180 166 
2 4108 Mrs.Mageshwari 14 14 0.4 0.3 0.2 0.3 20 16 21 18 186 159 
3 5099 Mr.G.Kannan 15 20 0.4 0.3 0.3 0.2 17 19 20 27 188 194 
4 5119 Mr.A.Anwar Hussain 29 17 0.6 0.3 0.3 0.4 15 12 18 14 170 163 
5 4215 Mrs.R.Sivagami 15 14 0.4 0.2 0.3 0.3 13 15 16 17 167 151 
6 4154 Mrs.P.Padmavathi 33 28 0.9 0.4 0.2 0.5 10 19 12 25 136 154 
7 5142 Mr.M.JayaKumar 22 28 0.6 0.3 0.4 0.4 12 18 14 25 166 143 
8 4961 Mr.M.HariKrishnan 14 17 0.5 0.4 0.3 0.2 24 16 31 24 168 142 
9 5036 Mr.Rajendren 31 25 0.7 0.2 0.6 0.3 15 21 17 28 140 136 
10 4270 Mrs.P.Jayagandhi 21 18 0.6 0.2 0.2 0.4 17 28 19 30 175 153 
11 4256 Mrs.K.Angammal 19 14 0.5 0.2 0.2 0.4 10 15 11 17 125 187 
12 4281 Mrs.A.Krishnaveni 14 18 0.5 0.2 0.5 0.3 18 14 20 17 175 149 
13 4282 Mrs.S.Savithri 15 17 0.5 0.3 0.3 0.4 2 19 31 23 197 173 
14 4135 Mrs.Jayalakshmi 16 19 0.5 0.2 0.2 0.4 18 20 35 22 164 181 
15 3981 Mrs.Sowndari 20 23 0.7 0.2 0.5 0.3 43 45 36 40 230 251 
16 3992 Mrs.Sundari 30 43 0.9 0.2 0.3 0.4 20 14 32 16 185 160 
17 4073 Mrs.Nirmala 14 14 0.4 0.2 0.1 0.3 26 12 28 13 163 145 
18 5030 Mr.SivaKumar 16 15 0.5 0.3 0.4 0.4 23 13 24 15 138 199 
19 5098 Mr.Mani 17 15 0.5 0.3 0.3 0.6 22 16 23 18 142 161 
20 5186 Mr.Ganesan 17 17 0.6 1 0.6 1.3 11 16 14 18 172 166 
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IN-PATIENT’S LIPID PROFILE TEST CHART 
 
 
Sl.no Ip .no Name 
HDL 
(mg/dl) 
LDL 
(mg/dl)           
VLDL 
(mg/dl) 
Total 
Cholestero
l(mg/dl) 
Triglyceri
des 
(mg/dl) 
BT AT BT AT BT AT BT AT BT AT 
1 5060 Mr.Chelladurai 45 37 128 93 19 16 193 195 96 84 
2 4108 Mrs.Mageshwari 34 44 115 110 38 32 183 232 191 161 
3 5099 Mr.G.Kannan 30 33 112 117 23 26 143 162 117 103 
4 5119 Mr.A.Anwar Hussain 30 45 76 101 23 31 120 217 117 158 
5 4215 Mrs.R.Sivagami 32 30 80 70 26 33 127 125 133 166 
6 4154 Mrs.P.Padmavathi 36 32 101 96 43 38 152 164 217 194 
7 5142 Mr.M.JayaKumar 33 35 96 98 33 31 163 170 167 152 
8 4961 Mr.M.HariKrishnan 27 32 90 82 48 34 139 142 242 134 
9 5036 Mr.Rajendren 31 35 86 92 24 32 145 160 120 117 
10 4270 Mrs.P.Jayagandhi 31 26 68 55 13 17 126 115 68 88 
11 4256 Mrs.K.Angammal 36 35 132 81 24 14 191 151 120 69 
12 4281 Mrs.A.Krishnaveni 39 38 96 101 17 30 190 207 88 151 
13 4282 Mrs.S.Savithri 36 35 92 83 31 35 194 174 158 177 
14 4135 Mrs.Jayalakshmi 35 36 112 88 28 14 184 176 123 72 
15 3981 Mrs.Sowndari 40 37 144 94 99 75 199 176 495 375 
16 3992 Mrs.Sundari 30 50 98 105 26 23 208 206 130 116 
17 4073 Mrs.Nirmala 36 36 123 87 51 82 207 187 259 184 
18 5030 Mr.SivaKumar 34 35 215 96 17 71 158 209 86 356 
19 5098 Mr.Mani 39 40 127 101 40 27 186 213 203 136 
20 5186 Mr.Ganesan 30 30 72 75 35 61 150 140 503 306 
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IN-PATIENT’S   URINE   INVESTIGATION   CHART 
 
Sl.no Ip .no Name 
   Albumin       Sugar                 Deposits 
BT AT BT AT        BT        AT 
1 5060 Mr.Chelladurai Nil  Nil  Nil  Nil  1-2Pus,1-2Epi 1-2Pus, 2-4Epi 
2 4108 Mrs.Mageshwari Nil  Nil  Nil  Nil  4-5Pus,1-2Epi 2-4Pus,2-4Epi 
3 5099 Mr.G.Kannan Nil  Nil  Nil  Nil  1- 2Pus, 1-2 Epi 1-2Pus, 2-4 Epi 
4 5119 Mr.A.Anwar Hussain Nil  Nil  Nil  Nil  1-2Pus, 2-3 Epi 1-2Pus, 1-2 Epi 
5 4215 Mrs.R.Sivagami Nil  Nil  Nil  Nil  2-3 Pus,1-2 Epi 1-2Pus, 1-2 Epi 
6 4154 Mrs.P.Padmavathi Nil  Nil  Nil  Nil  2-4Pus, 1-2 Epi 1-2Pus, 1-3 Epi 
7 5142 Mr.M.JayaKumar Nil  Nil  Nil  Nil  2-3Pus, 2-3 Epi 1-2Pus, 1-2 Epi 
8 4961 Mr.M.HariKrishnan Nil  Nil  Nil  Nil  2-3Pus 2-3 Epi 1-3 Pus 1-2 Epi 
9 5036 Mr.Rajendren Nil  Nil  Nil  Nil  1-2Pus, 1-2Epi 1-2Pus, 1-3 Epi 
10 4270 Mrs.P.Jayagandhi Nil  Nil  Nil  Nil  2-4Pus, 2-4Epi 1-2Pus, 1-2Epi 
11 4256 Mrs.K.Angammal Nil  Nil  Nil  Nil  1-2Pus,1-2Epi 2-3Pus,1-2Epi 
12 4281 Mrs.A.Krishnaveni Nil  Nil  Nil  Nil  2-4Pus,3-6Epi 2-4Pus,1-2Epi 
13 4282 Mrs.S.Savithri Nil  Nil  Nil  Nil  1-2Pus,2-4Epi 2-4Pus,2-4Epi 
14 4135 Mrs.Jayalakshmi Nil  Nil  Nil  Nil  1-2Pus,2-3Epi 2-4Pus,2-4Epi 
15 3981 Mrs.Sowndari Nil  Nil  Nil  Nil  3-6Pus, 4-8 Epi 6-8Pus, 4-5 Epi 
16 3992 Mrs.Sundari Nil  Nil  Nil  Nil  1-2Pus, 2-4 Epi 3-5Pus, 3-5 Epi 
17 4073 Mrs.Nirmala Nil  Nil  Nil  Nil  1-2Pus, 1-2 Epi 1-2Pus, 2-4 Epi 
18 5030 Mr.SivaKumar Nil  Nil  Nil  Nil  1-2Pus, 1-2 Epi 1-2Pus, 2-4 Epi 
19 5098 Mr.Mani Nil  Nil  Nil  Nil  1-2Pus, 1-3 Epi 2-4Pus, 2-4 Epi 
20 5186 Mr.Ganesan Nil  Nil  Nil  Nil  2-3Pus, 1-2 Epi 1-2Pus, 1-2 Epi 
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NATIONAL INSTITUTE OF SIDDHA 
ACUTE TOXICITY STUDY OF KUKKILAATHI CHOORANAM 
[WHO guidelines, 1993] 
Principle: 
    Acute toxicity was carried out in Swiss albino mice with a single exposure of 
10 times of the recommended therapeutic dose of test compound the study duration will be 14 
days. 
Animal species  : Swiss albino mice 
Age / Weight / Size  :  6 weeks.  Mice-20-25 gms. 
Gender   :   Both male and female 
Number of Animals   : Mice: 10 
Acclimatization Period : 7 Days 
Clinical dose   : 3.0 gms\day 
S.No Group No of mice 
1 Vehicle control (saline) 10  (5 male, 5 female) 
 
2 
Toxic dose 
10 X therapeutic dose 
(0.054gms) 
10  (5 male, 5 female) 
Test Animals  
      Test animals were obtained from the animal laboratory of the King institute, Chennai 
and stocked at National institute of siddha, Chennai. All the animals were kept under standard 
environmental condition (27+ or – 2 degree c).The animals had free access to water and 
standard pellet diet (Sai Durga foods pvt.ltd, Bangalore).The principles of laboratory animal 
care were followed and the  Institutional ethical committee approved the use of animals and 
the study design. (1248/ac/09/CPCSEA/4-24/ 2011). 
 Route of administration: 
 Oral route was selected, because it is the normal route of clinical administration. 
Test substance and vehicle 
       Kukkilaathi chooranam was Brown in colour.  The test substance was insoluble in 
water, in order to obtain and ensure the uniformity in drug distribution the drug was dissolved 
by aqueous Tween 80 solution (10%).  
105 
 
Administration of doses 
           Kukkilaathi chooranam was suspended in aqueous Tween 80 solution (10%), with 
uniform mixing and it was administered to the groups in a single oral dose. The control 
groups received equal volume of the vehicle. The animals were weighed before giving the 
drug. The dose level was calculated according to body weight and surface area. Since the 
clinical dose was 3.0gms\day it was converted to animal dose (0.054gms) and then 
administered. The principle of laboratory animal care was followed. 
Observations 
 Observations were made and recorded systematically and continuously observed as 
per the guideline after substance administration. The animals were monitored for behavioural 
parameters like 
1. Awareness 
- Alertness 
- Visual placing 
- Stereotype 
- Passivity 
2. Mood 
-  Grooming 
-  Restlessness 
-  Irritability 
-  Fearfulness 
3. Motor activity 
- Spontaneous activity 
- Reactivity 
- Touch response 
- Pain response.  
Animals were observed for body weight and mortality for 14 days. If animals died 
during the period of study, the animals were sacrificed.  At the end of the 14th day all animals 
were sacrificed and necropsy was done. 
Body Weight 
 Individual weight of animals was determined before the test substance was 
administered and daily for 14 days. Weight changes were calculated and recorded. At the end 
of the test, serving animals were weighed and sacrificed. 
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Results:   
At the dose 0.054gms/animal did not exhibit any mortality in mice. 
 No behavior changes were noted for the first 4 hours and for the next 24 hours and 
throughout the study period of 14 days. No weight reduction was noted before and after the 
acute study duration. Reflexes were found to be normal before and after the study. All other 
observations were found to be normal before and after the study. In Necropsy, the organs of 
the animal such as, Liver, Heart, Lungs, Pancreas, Spleen, Stomach, Intestine, Kidney, 
Urinary bladder, Uterus all appeared normal. 
BIO - CHEMICAL ANALYSIS OF  KUKKILAATHI CHOORANAM ANALYSED 
AT NATIONAL INSTITUTE OF SIDDHA 
S.
No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of sample Brown in colour  
2. Solubility: 
a. A little (500mg) of the sample is shaken well 
with distilled water. 
b. A little (500mg) of the sample is shaken well 
with con. HCl/ Con. H2So4. 
Sparingly soluble 
 
 
Presence of 
Silicate 
3. Action of Heat: 
   A small amount (500mg) of the sample is 
taken in a dry test tube and heated gently at 
first and then strong. 
White fumes not 
evolved 
 
 
 
Absence of 
Carbonate 
 
4. Flame Test: 
  A small amount (500mg) of the sample is 
made into a paste with con. HCl in a watch 
glass and introduced into non-luminous part of 
the Bunsen flame. 
No Bluish green 
flameappeared. 
Absence of 
Copper 
5. Ash Test: 
A filter paper is soaked into a mixture of 
sample and dil. cobalt nitrate solution and 
introduced into the Bunsen flame and ignited 
No Yellow 
coloured flame 
Absence  of 
Sodium 
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Preparation of Extract:  5gm of Kukkilaathi chooranam is weighed accurately and placed in 
a 250ml clean beaker and added with 50ml of distilled water. Then it is boiled well for about 
10 minutes. Then it is cooled and filtered in a 100ml volumetric flask and made up to 100ml 
with distilled water. 
S.No EXPERIMENT OBSERVATION INFERENCE 
I. TEST FOR ACID RADICALS 
1.  Test For Sulphate: 
a.2ml of the above prepared extract is taken in 
a test tube to this added 2ml of 4% dil. 
ammonium oxalate solution 
No Cloudy 
appearance 
present 
Absence  
of  Sulphate 
2. Test For Chloride: 
2ml of the above prepared extracts is added 
with 2ml of dil-HCl is added until the 
effervescence ceases off. 
No cloudy 
appearance 
present 
Absence 
of Chloride 
3. Test For Phosphate: 
2ml of the extract is treated with 2ml of 
dil.ammonium molybdate solution and 2ml of 
con.HNo3 
No cloudy yellow 
appearance 
present 
Absence 
of Phosphate 
4.  Test For Carbonate: 
2ml of the extract is treated with 2ml dil. 
magnesium sulphate solution. 
No Cloudy 
appearance 
present 
Absence 
of Carbonate 
5 Test For Nitrate: 
1gm of the substance is heated with copper 
turning and concentrated H2So4 and viewed 
the test tube vertically down. 
No Brown gas  
evolved 
Absence  
of Nitrate 
6. Test For Sulphide: 
1gm of the substance is treated with 2ml of 
con. HCL 
No Rotten Egg 
Smelling gas 
evolved 
Absence 
of Sulphide 
7. Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of dil. Acetic 
acid and 2ml dil.calcium chloride solution and 
heated. 
No Cloudy         
appearance 
Absence  
of Fluoride and 
Oxalate 
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8. 
 
Test For Nitrite: 
3drops of the extract is placed on a filter paper, 
on that-2 drops of dil.acetic acid and 2 drops 
of dil. Benzidine solution is placed. 
No characteristic 
changes 
 
Absenceof 
Nitrite 
9. Test For Borate: 
  2 Pinches (50mg) of the substance is made 
into paste by using dil.sulphuric acid and 
alcohol (95%) and introduced into the blue 
flame. 
Bluish green 
colour flame did 
not appear. 
   Absence  
of Borate 
II. TEST FOR BASIC RADICALS 
1. Test For Lead: 
2ml of the extract is added with 2ml of 
dil.potassium iodine solution. 
No Yellow 
Precipitate is 
obtained. 
Absence of 
Lead 
2. Test For Copper: 
a. One pinch(50mg) of substance is made into 
paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the 
flame. 
 
No Blue colour 
flame 
No Blue colour 
precipitate 
formed. 
Absence 
of Copper 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium hydroxide is 
added in 5 drops to excess. 
No characteristic 
changes 
  Absence 
of Aluminium 
4. Test For Iron: 
a.To the 2ml of extract add 2ml of 
dil.ammonium solution 
b.To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
 
Red colour 
appeared 
 
Presence Of 
Iron 
5. Test For Zinc: 
    To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
White precipitate 
is not 
Formed 
 
Absence of 
Zinc. 
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6. Test For Calcium:  
2ml of the extract is added with 2ml of 4% 
dil.ammonium oxalate solution  
No Cloudy 
appearance and 
white precipitate  
was obtained. 
   Absence  
of Calcium 
7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide 
solution is added in drops to excess. 
No White 
precipitate was  
obtained 
   Absence 
of Magnesium 
8. Test For Ammonium: 
  To 2ml of extract 1 ml of Nessler's reagent 
and excess of dil.sodium hydroxide solution 
are added. 
No Brown colour 
appeared 
     Absence  
 of Ammonium 
9. Test For Potassium:  
   A pinch (25mg) of substance is treated of 
with 2ml of dil.sodium nitrite solution and 
then treated with 2ml of dil.cobalt nitrate in 
30% dil.glacial acetic acid. 
 
No Yellowish 
precipitate was 
obtained. 
 
   Absence  
of Potassium 
10. Test For Sodium: 
    2 pinches (50mg) of the substance is made 
into paste by using HCl and introduced into 
the blue flame of Bunsen burner. 
 No Yellow 
coloured flame 
appeared 
Absence 
of Sodium 
11. Test For Mercury:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution.  
No yellow 
precipitate was 
obtained. 
Absence of 
Mercury 
12. Test For Arsenic:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution. 
No brownish red 
precipitate was 
obtained. 
Absence 
of Arsenic 
III. MISCELLANEOUS 
1.
  
Test For Starch:  
2ml of extract is treated with weak 
dil.Iodine solution  
 
No Blue colour 
developed 
 
Absence  
of Starch 
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2.
  
Test For Reducing Sugar:  
    5ml of Benedict's qualitative solution is 
taken in a test tube and allowed to boil for 
2 minutes and added 8 to 10 drops of the 
extract and again boil it for 2 minutes. The 
colour changes are noted. 
 
Brick red colour 
developed 
 
Absence of 
Reducing sugar. 
3.
  
Test For The Alkaloids: 
a) 2ml of the extract is treated with 2ml of 
dil.potassium lodide solution. 
b)  2ml of the extract is treated with 2ml of 
dil.picric acid. 
c)  2ml of the extract is treated with 2ml of 
dil.phosphotungstic acid. 
 
Red colour developed 
 
Yellow colour 
developed 
White precipitate 
developed 
 
 
 
  Presence  
of Alkaloid 
4.
  
Test For Tannic Acid:  
  2ml of extract is treated with 2ml of 
dil.ferric chloride solution  
 
No black precipitate 
was obtained 
Absence of 
Tannic acid 
5.
  
Test For Unsaturated Compound: 
  To the 2ml of extract 2ml of 
dil.Potassium permanganate solution is 
added.  
 
Potassium 
permanganate is not 
decolourised 
 
Absence of 
unsaturated 
compound 
6.
  
Test For Amino Acid: 
    2 drops of the extract is placed on a 
filter paper and dried well. 20ml of  
Biurette reagent is added. 
 
No Violet colour 
developed 
 
   Absence   
of Amino acids 
111 
 
7. Test For Type Of Compound: 
    2ml of the extract is treated with 2 ml of 
dil.ferric chloride solution.  
  
 
No Green colour 
developed 
 
 
 
No Red colour 
developed 
 
 
 
No Violet colour 
developed 
 
 
 
 
No blue colour 
 developed 
 
Absence of oxy 
quinole 
epinephrine 
and pyro 
catechol. 
 
Anti pyrine, 
Aliphatic          
amino acids and 
Meconic acid 
are absent. 
 
Apomorphine, 
Salicylate and 
Resorcinol are 
absent. 
 
Morphine, 
Phenol 
cresol and 
hydro 
quinone are 
absent 
  
 
RESULT: 
The bio-chemical analysis of Kukkilaathi chooranam had shown the presence of   
Silicate, Iron, and Alkaloids. 
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DISCUSSION 
 Varatchi Karappan (Eczema) is one of the commonly encountered skin diseases in 
day-to-day dermatological practice. Eczema is uncomfortable, itchy with inflamed, cracked 
and serous discharging lesions. Eczema occurs when skin is more sensitive to certain 
substances than normal. The appearance, severity, symptoms and triggers of eczema vary 
between individuals. It is not a contagious disease. Eczema is generally not a serious 
condition, but there is a potential for complications, such as a secondary bacterial or fungal 
infection of the eczema rash. Early diagnosis and treatment can reduce the risk for 
complications. Remissions and relapse of this disease is quite common and there is no 
specific treatment available in other systems of medicine. The psychological impacts are 
feelings of self-consciousness, frustration and shame, often leading to severe mental 
depression. However encouraging results are obtained in our Siddha system. With this 
background the disease Varatchi Karappan was chosen for the dissertation work.  
For this dissertation study, 40 patients were selected and 20 patients were admitted in 
the IP department of Sirappu Maruthuvam, in Ayothidoss Pandithar Hospital - National 
Institute of Siddha, Tambaram Sanatorium, Chennai - 47 and 20 patients were treated in the 
Outpatient department of Sirappu Maruthuvam. 
            In Siddha system, before starting the treatment it is necessary to bring the vitiation of 
Uyirthathu to equilibrium. By giving purgation we can normalize the deranged Vaatham.  
            In this study, purgation with Agathiyar Kuzhambu – 130mg with Sangangkuppi juice 
at early morning was given for balancing the deranged Uyirthathu a day before treatment for 
all the patients.  
The trial drugs Kukkilaathi chooranam (Internal) and Karappan mel poosu thylam 
(External) were given for 48 days. Out-Patients were asked to visit the hospital once in 7 days 
for 48 days after that they were asked to visit once in 5 days for the next 2 months. For Out-
Patients the drugs were given for 48 days and the clinical assessment was done on 0th day, 7th 
day, 14th day, 21th day, 29th day ,36st day, 43rd day and 49th day.  
 For In-Patients the drugs were given for 48 days and the clinical assessment was 
done daily. 10 In-Patients were given Yogam treatment along with the trial drugs. The results 
were compared at the end of the study. For In-Patients, who are not in a situation to stay in 
the hospital for a long time, were advised to attend the Out-Patient Department of Sirappu 
Maruthuvam for further follow- up for two months. 
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Patients were advised to take the medicines regularly and apply the external medicine 
twice a day. During treatment, the patients were advised to follow Pathiyam (Dietary 
regimen). Since most of the patients were severely affected by this disease, they were advised 
to avoid Salt, Tamarind, Brinjal, Dryfish, fish, chicken, Bitter gourd, Sesban greens, egg, 
maize during treatment. It was ensured that the diet restrictions imposed were followed 
properly by the patients. 
After the treatment, the patients were advised to visit the Out-Patient Department of 
Sirappu Maruthuvam for another 2 months for follow-up.  
 Based on various criteria, the data were collected and tabulated. The criteria were 
family history, sex predominance, age distribution, dietary habits and incidence of the disease 
with reference to thinai, seasonal variation, clinical manifestations and assessment of the 
improvement in the prognosis of the disease with the trial drug. 
 Among 40 cases recruited to this study, 1 case had a strong family history. Recent 
studies regarding eczema also emphasize on this concept that eczema has a genetic 
predisposition. 
          40 patients of both genders were recruited for this study. Among the 40 cases 22 (55%) 
were males and 18 (45%) were females. Generally Eczema affects both the sexes, but in this 
study shows more number of cases were reported in Males. 
3 (7.5%) patients were in the age group between 20 and 30 years, 7 (17.5%) patients 
were between 31 and 40 years, 14 (35%) patients were between 41 and 50 years, 16 (40%) 
patients were between 51 and 60 years. Karappan affects people of all the age groups. In this 
study most of the cases were reported in the age group 51 to 60 years. 
Highest number of patients (55.00%) was admitted during Kaar Kaalam.   
  38 (95%) patients were non vegetarians and only 2 (5%) were vegetarians. According 
to Siddha literature, non- vegetarian foods are one of the precipitating factors for skin 
diseases. This present study also emphasizes the same.  
           In this present study, considerable number of patients was reported from Neithal thinai. 
In Siddha literature, it is mentioned that kabam is predominant in Neithal thinai. As vitiated 
kabam is responsible for eczema, majority of patients from Neithal thinai are affected.  
           Viyanan and Samanan were affected in all the cases (100%). Devathathan was affected 
in 20% of the cases, Abaanan in 15% of the cases and Kirukaran in 10% of cases. 
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Praasakam were affected in all the 40 (100 %) patients. Praasakam is responsible for 
the complexion of the skin. Hence the defect in Praasakam may lead to the causative factor 
for this disease.  
Kilethakam was affected in 4(10%) patients, Santhikam was affected in 7(17.5%) 
patients, and Anarpitham was affected in 4 (10%) patients. 
Saaram and Senneer were affected in all the 40 (100%) cases. Saaram and Senneer are 
responsible for the color of the skin. Niram and Sparisam were affected in all the 40 (100%) 
cases. In Karappan, the color of skin changes into black along with itching, oozing, scaling 
and crusting. Among 40 cases, all cases had itching and oozing, hyperpigmentation, 21 
patients had scaling, 12 patients had vesicles, 8 patients had papules, 5 patients had erythema, 
5 patients had hypopigmentation and 24 patients had lichenification. Itching, oozing and 
scaling shows good reduction whereas hyperpigmentation shows only moderate reduction. 
 Laboratory investigations were done for all the cases before and after treatment.   
There were no significant variations in hepatic, renal and other parameters before and after 
treatment. Among the 20 IPD patients 10 patients were taught. Yogam therapy along with the 
trial medicines and the remaining 10 IPD patients received only internal and external 
medicine without any Yogam therapy. The patients who received Yogam therapy along with 
trial medicines responded well since the Yogam therapy is mainly aimed to reduce the stress 
in the affected individual which plays a vital role in rapid prognosis and relapse of this 
disease.  
          The outcome of this study also showed encouraging results. Moderate improvement 
(Grade II) in 25 patients (62.5%), mild improvement (Grade III) in 12 cases (30%). No 
improvement (Grade IV) in only 3 cases (7.5%). The symptoms of itching, scaling, oozing 
and hyperpigmentation before and after treatment were considered for arriving clinical 
symptom score by using paired T test. There was a significant difference in clinical symptom 
score before and after treatment (P<0.001). 
 In this study, no adverse events were clinically observed during the course of the 
treatment. At the time of discharge all the patients were advised to attend outpatient 
department of Sirappu Maruthuvam of National Institute of Siddha for follow-up treatment. 
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SUMMARY 
               The disease Varatchi Karappan was taken for the clinical study with Kukkilaathi 
chooranam as internal medicine and Karappan melpoosu thylam as external application.  For 
the clinical study, 40 cases were selected based on Inclusion and Exclusion criteria. 
             The study is conducted after the drug being screened by the Screening committee of 
National Institute of Siddha and the trial was also approved by the Institutional Ethical 
Committee (IEC). Animal studies are carried out after obtaining proper permission from the 
Institutional Animal Ethical Committee (IAEC). Hence the study is safely executed on 
human volunteer patients and there was no adverse drug reactions noted during the study 
period. 
             Out of the 40 cases, 20 cases were treated in IPD and remaining 20 cases were 
treated in OPD of Ayothidoss Pandithar Hospital of National Institute of Siddha, Chennai-47. 
The detailed study on Varatchi Karappan with reference to its Aetiology, Pathogenesis, 
Investigations, Clinical features, Diagnosis and Treatment with trial drugs was done. Separate 
proforma was maintained for each and every patient. Daily progress chart was also 
maintained to monitor the clinical signs and symptoms of the disease.  
           Among the 20 IPD patients 10 patients were taught Yogam therapy along with the 
above said internal and external medicines and the remaining 10 IPD patients received only 
internal and external medicine without any Yogam therapy being taught to them. The patients 
who received Yogam therapy along with their medications responded well since the Yogam 
therapy is mainly aimed to reduce the stress in the affected individual which plays a vital role 
in better prognosis and relapse of this disease. 
          Among the 40 cases treated, 62.5% cases had shown Moderate improvement (GRADE 
II), 30% cases had shown Mild improvement(GRADE III) and 7.5% cases without any 
improvement.Observation made during the clinical study showed that the trial drug was 
clinically effective.  
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CONCLUSION 
 Varatchi Karappan is one of the chronic skin diseases, which threatens the mankind. 
In this clinical study “Kukkilaathi chooranam” and “Karappan melpoosu thylam” were taken 
as Internal & External drug respectively.  The above medicines were selected from the 
Siddha literatures “Sarabaendhira Vaidhya Muraigal Virana karappan roga sikichai 
(Pg.No.264)” and “Vaidhya sinthamani- Sikicha Rathna Deepam-Page. no.205” respectively. 
 The clinical study confirms the efficacy of the trial drugs by reducing the clinical 
signs and symptoms like Itching, Oozing and Scaling. Clinical study results found to be 
Moderate in 62.5% cases, Mild in 30% cases and no improvement in 7.5% cases. 
 The cost of the trial medicines is low. These drugs are easily available and the dosage 
is also convenient. 
The Clinical trial conducted in selected patients was satisfactory and encouraging. 
However a study with large number of patients is required to find out the ideal dose response.  
Yogam treatment along with internal and external medication is found to be more 
effective in sleeplessness. The subjects affected by Eczema are most commonly affected by 
stress and social stigma. When these affected communities get a good improvement with this 
new drug and Yogam, it would be a great outcome for the people. 
In the present study there was no adverse effect were reported and in the animal 
studies also shown no abnormality. Hence the drugs are considered as safe. However further 
work with large number of patients should be carried out towards finding the ideal dose 
response. 
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                                           NATIONAL  INSTITUTE  OF  SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE -CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
FORM l - SCREENING & SELECTION PROFORMA 
1. OP /IP NO: -------------                 
2. NAME:  ………………………………………….   
3. AGE:      ………                                                      4.GENDER: …………....... 
5. OCCUPATION: ………………………………..      6.INCOME:   ………………… 
7. ADDRESS:    ……………………………………     
…………………………………… 
…………………………………… 
8. CONTACT NO:    ……………………………………              
INCLUSION CRITERIA 
· Age: 20 – 60 years                                                                                             Yes / No 
· Sex: Both male and female                                                      M / F 
· Itching                                                                                                                   Yes / No 
· Oozing                                                                                                                  Yes / No 
· Erythema                                                                                           Yes / No 
· Papules                                                                                                                 Yes / No 
· Vesicles                                                                                                                Yes / No 
· Scaling                                                                                               Yes / No 
· Hyperpigmentation                                                                                           Yes / No 
· Willing to give specimen of blood for investigation when required  Yes / No 
· Willing for admission and study in IPD for 48 days or willing to attend OPD Yes / No 
EXCLUSION CRITERIA 
●   Hypertension                                                 Yes / No 
· Diabetes mellitus       Yes / No 
· Cardiac disease        Yes / No  
· Pregnancy and lactation       Yes / No 
· Evidence of any skin disease other than eczema   Yes / No  
· Varicose eczema                                                                                                 Yes / No 
· ADMITTED TO TRIAL  
                       YES   NO  
 
    If yes              OPD                 IPD 
 
   
  If Yes Serial NO: 
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD   
 
 
     
 
 
  
NATIONAL INSTITUTE OF SIDDHA  -  AYOTHIDOSS PANDITHAR HOSPITAL 
                                                       CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE -CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
     FORM lI - HISTORY TAKING PROFORMA 
1. SERIAL NO: …………………   2.OP / IP NO: ..........................  
 3. NAME: …………………………… 4. AGE: …………       5.GENDER: .................                           
6. COMPLAINTS & DURATION:   
                                                                                                                                                                
7. HABITS OF 
  SMOKING    1. Yes               2.No                  If yes, specify duration    ---------- yrs 
    TOBACCO   1. Yes               2.No               If yes, specify duration    ---------- yrs 
  ALCOHOL   1. Yes               2.No               If yes, specify duration    ---------- yrs               
8. DRUG HISTORY: 
 
9. FAMILY HISTORY:    Whether this problem runs in family  1. Yes                2.No         
    If yes, mention the relationship of affected person(s) 
                                               1._________________  2._________________                              
10.DIETARY HABIT:         1.Vegetarian            2.Non-vegetarian 
11. MENSTRUAL  & OBSTETRIC  HISTORY: 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD   
NATIONAL INSTITUTE OF SIDDHA - AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE- CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
    FORM III -CLINICAL ASSESSMENT ON ENROLLMENT  
1.OP NO:  ------------ 2.IP NO: ---------------    3.BED NO: ------     4.SI NO:   ------ 
5. NAME: ----------------------        6. AGE:   ---------              7.GENDER:    ------ 
8. DATE OF INITIAL ASSESSMENT:     ----------------------             
9. GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cm]                        :                        
3. Body Temperature [F]       :   
4. Blood Pressure (mmHg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.  :   
                                                                                   Yes            No   
8. Pallor  :   
9. Jaundice  :   
10. Clubbing  : 
11. Cyanosis  : 
12. Pedal Oedema : 
13. Lymphadenopathy           :                                        
14. Jugular venous pulsation  :   
 
 
 
 
1. SYSTEMIC EXAMINATION: 
Nervous system   -----------------------               Cardiovascular system ---------------------- 
 
Uro-genital system -----------------------                Respiratory system ---------------------- 
 
Endocrine system   -----------------------                Gastro intestinal system ------------------- 
11. SIDDHA SYSTEM OF EXAMINATION  
  1. THEGI (BODY CONSTITUTION): 
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal                                                  ………………………                                                  
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
            5. Paalai (Arid regions) 
 
 
3. KAALAM: 
1. Kaar kaalam  (Aavani-Purattasi)                     2. Koothir kaalam    (Ippasi-Kaarthigai)               
3. Munpani kaalam  (Maargazhi-Thai)               4. Pinpani kaalam     (Maasi-Panguni)         
5. Ilavenil kaalam  (Chithirai-Vaigasi)               6. Muthuvenil kaalam (Aani-Aadi) 
 
4. GUNAM:             1. Sathuvam              2. Rasatham               3. Thamasam 
 
5. PORIPULANGAL (SENSORY ORGANS):          
6. KANMENDRIYAM (MOTOR ORGANS) 
 
7. KOSANGAL (SHEATH):          
Before Treatment After Treatment 
Annamayakosam Normal  /Affected Normal  /Affected 
Pranamayakosam  Normal  /Affected Normal  /Affected 
Manomayakosam  Normal  /Affected Normal  /Affected 
Vignanamayakosam  Normal  /Affected Normal  /Affected 
Ananthamayakosam  Normal  /Affected Normal  /Affected 
 
 Before Treatment After Treatment 
Mei  Normal  /Affected Normal  /Affected 
Vaai Normal  /Affected Normal  /Affected 
Kann Normal  /Affected Normal  /Affected 
Mookku Normal  /Affected Normal  /Affected 
Sevi Normal  /Affected Normal  /Affected 
 Before treatment  After treatment 
Kai  Normal  /Affected Normal  /Affected 
Kaal  Normal  /Affected Normal  /Affected 
Vaai    Normal  /Affected Normal  /Affected 
Eruvai Normal  /Affected Normal  /Affected 
Karuvai  Normal  /Affected Normal  /Affected 
8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI, AZHAL,IYAM) 
A) VALI 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
B) AZHAL 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Analakam         
Ranjakam          
Saathakam          
Praasakam          
Aalosakam         
 
 
C) IYAM 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Avalambagam         
Kilethagam         
Bothagam         
Tharpagam         
Santhigam         
9.SEVEN UDAL DHATHUS: (7 SOMATIC COMPONENTS)  
 Before Treatment After Treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai  Normal  /Affected Normal  /Affected 
Sukkilam/Suronitham  Normal  /Affected Normal  /Affected 
 
SIDDHA SYSTEM OF EXAMINATION 
1. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
 
Naadi 
Nadai 
0th  
day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
II .SPARISAM: 
III. NAA:[TONGUE] 
IV.NIRAM: [COMPLEXION]   
V.MOZHI: [VOICE] 
 
VI.VIZHI: [EYES]  
 
 
 
Sparisam 0th  
Day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
Naa 0th  
Day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
Niram 0th  
Day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
Mozhi 0th  
Day 
8th 
day 
15th  
day 
22th  
day 
29th  
day 
36th  
day 
43th  
day 
49th  
day 
High Pitched         
Medium Pitched         
Low Pitched         
Vizhi 0th  
Day 
8th 
day 
15th  
day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
VII. MALAM: [BOWEL HABITS / STOOLS] 
Malam     Before treatment After treatment 
                          Niram   
                          Irugal   
                          Ilagal   
                          Others   
 
VIII. URINE EXAMINATION 
  
NEIKKURI Before Treatment After Treatment 
Serpentine pattern   
Annular/Ringed pattern   
Pearl beaded  pattern   
Mixed pattern   
Other pattern   
 Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
 
  
NEERKKURI Before Treatment After Treatment 
Niram    
Manam   
Edai    
Nurai   
Enjal   
NATIONAL INSTITUTE OF SIDDHA. 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE -CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
                 FORM IV -     CLINICAL ASSESSMENT DURING & AFTER TRIAL 
1. OP/ IP NO: …………      2. SL. NO: ………    3.NAME: ………………………….               
4. AGE: ………                    5. GENDER: …...     6. DATE OF RECRUITMENT: …… 
 
 0day  7th day 14th day  21th day 
Site      
Itching     
 Oozing     
Erythema     
Oedema     
Papules     
Vesicles     
Scaling     
Hyper    
pigmentation 
    
Lichenification     
 
 
 
  29th day           36th day            43th day           49th day 
Site      
Itching     
 Oozing     
Erythema     
Oedema     
Papules     
Vesicles     
Scaling     
Hyper    
pigmentation 
    
Lichenification     
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
 
 
 
 
 
 
                                           NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
       CHENNAI – 600 047. 
POST -GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE- CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
.FORM-V - LABORATORY INVESTIGATIONS 
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE TMT 
(WITH DATE) 
AFTER TMT 
(WITH DATE) 
 
HB( gm/dl) 
M:13-18 
W:11-16 
  
 
T.WBC (cells/cu.mm) 
4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
 
T.RBC(million cells/cu.mm) 
M:4.0-5.5 
W:3.5-4.5 
 
 
 
 
  ESR(mm/hour) ½ hr. M:6-12 
W:7-18 
  
  1 hr.   
Blood 
glucose 
(mg/dl) 
Fasting    70-110   
PP    80-140   
Random    80-120   
Lipid profile 
(mg/dl) 
HDL 30-60   
LDL Upto 130   
VLDL 40   
Total Cholesterol 150-200   
TGL Upto 160   
RFT (mg/dl) 
Blood urea    16-50   
Serum creatinine   0.6-1.2   
Uric acid    2-7   
LFT (mg/dl) 
Total bilirubin    0.2-1.2   
Direct bilirubin    0.1-1.2   
Indirect bilirubin    0.2-0.7   
SGOT     0-40   
SGPT     0-35   
Alkaline phosphatase    80-290   
  
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
 
 
 
URINE INVESTIGATION BEFORE TMT(WITH DATE) AFTER TMT (WITH DATE) 
Neer kuri   
Niram   
Edai   
Manam   
Nurai   
Enjal   
Nei kuri   
Albumin   
Fasting sugar   
PP sugar   
Deposits   
FORM VIII – PATIENT INFORMATION SHEET 
Name of Principal Investigator:…………………………… 
Name of the institute:   National Institute of Siddha, 
                                      Tambaram Sanatorium, 
                                      Chennai-47. 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN CLINICAL 
TRIAL. 
I, Dr. K. Kaviarasi  studying as PG Scholar at National Institute of  Siddha, 
Tambaram Sanatorium is doing a trial on Varatchi karappan (Eczema). Eczema is a chronic 
skin disease, occurring throughout the world. In this regard, I am in a need to ask you few 
questions. I will maintain confidentiality of your comments and  data  obtained . There will 
be no risk of disclosing your identity and no physical, psychological or professional risk is 
involved by taking part in this study. Taking part in this study is voluntary. No compensation 
will be paid to you  for  taking  part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in the 
study may be of benefit to the community, as it may help us to understand the problem of 
defaulters and potential solutions. If you agree to be a participant in this study, you will be 
included in the study primarily by signing the consent form and then you will be given the 
internal medicine  Kukkilaathi chooranam(Internal medicine-1.5gm , BD with water for 48 
days) and Karappan mel poosu thylam (External medicine). If you wish to stay in the In 
Patient ward Yogam Treatment will be provided to you assuring that you will not be 
definitely hurt in any course of treatment. 
  The information I am collecting in this study will remain between you and the 
principal investigator (myself). I will ask you few questions through a questionnaire.  
If you wish to find out more about this study before taking part, you can ask me all 
the questions you want or contact Dr.K.Kaviarasi, PG Scholar cum principal investigator of 
this study, [contact no -9677360596 ] attached to National Institute of Siddha,Chennai-47. 
You can also contact the Member-secretary of  Ethics committee, National Institute of 
Siddha, Chennai 600047, Tel No : 91-44-22380789, for rights and participation in the study.   
 
 
 
FORM VI - ´ôÒ¾ø ÀÊÅõ 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
¿¡ý ¸ÃôÀ¡ý ±ýÛõ §¿¡Â¢ý ¬ö¨Å ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ 
§¿¡Â¡Ç¢ìÌô ÒÃ¢Ôõ Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 
§¾¾¢:                                                              ¨¸¦Â¡ôÀõ: 
þ¼õ:               ¦ÀÂ÷:                                               
                                         
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
 
±ýÉ¢¼õ þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨È ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ ±ÉÐ ¯¼ø þÂì¸ò¨¾ì ¸ñ¸¡½¢ì¸×õ, 
«¾¨É À¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢ ¾¢Õô¾¢ 
«Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ þó¾ 
¬öÅ¢Ä¢ÕóÐ ±ý¨É Å¢ÎÅ¢òÐì ¦¸¡ûÙõ ¯Ã¢¨Á¨Âò ¦¾Ã¢ó¾¢Õì¸¢ý§Èý. 
¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ò §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ  ¸ÃôÀ¡ý 
§¿¡öì¸¡É Ìì¸¢Ä¡¾¢ ÝÃ½õ (¯û ÁÕóÐ) ÁüÚõ ¸ÃôÀ¡ý §Áø âÍ ¨¾Äõ (¦ÅÇ¢ 
ÁÕóÐ) ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ¯ðÀÎò¾ 
´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 
§¾¾¢:                                          ¨¸¦Â¡ôÀõ: 
þ¼õ:               ¦ÀÂ÷:         
 
§¾¾¢:                                 º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
þ¼õ:                                          ¦ÀÂ÷:                          
                                                   ¯È×Ó¨È:          
 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE -CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
FORM VI-CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered to 
my satisfaction.  
            I  consent  voluntarily to participate as a participant in this study and understand that I 
have the  right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:  
Signature of the participant: 
In case of illiterate participant: 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm that the 
individual has given consent freely.”                                                   
 
 
 
Date: 
 
 
 Signature of a witness  
(Selected by the participant bearing no connection with the survey team)          Left thumb Impression of the  
           Participant     
      
 
                                                
                                                  NATIONAL INSTITUTE OF SIDDHA 
                                AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE- CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
FORM VII - WITHDRAWAL FORM 
1. SERIAL NO OF THE CASE: …………………   
2. OP / IP NO: ......................................    
3. NAME: ……………………………    4.AGE: …………       5.GENDER: .................                          
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of  adverse event :                                            Yes/No 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD
                                            NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE- CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
DRUG COMPLIANCE FORM   
SERIAL NO:  
OP/IP NO: 
NAME:        
AGE/ GENDER:                                  
DRUG NAME:  Kukkilaathi  chooranam 
OPD: 
On 1st     day-Date:    Drugs issued: 21(Gms) Drugs returned:  (Gms) 
On 8th   day-Date:     Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 15th day-Date:         Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 22nd day-Date:         Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 29th day-Date:          Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 36th day-Date:          Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 43rd day-Date:          Drugs issued: 21(Gms) Drugs returned:   (Gms)  
IPD: 
Day Date Morning Evening Day Date Morning Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23    Day47    
Day24    Day48    
                    
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
 
 
 
           NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE -CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND      KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI  KARAPPAN”(ECZEMA). 
                                         YOGAM COMPLIANCE FORM 
                        [EFFECT OF YOGAM ALONG WITH TRIAL DRUG] 
SERIAL NO:  
MEDITATIVE POSTURES: 
            Tamarai asanam    (  Padhmasanam  ) , 
            Sukhasanam 
 Mandi  uruthi asanam (vajrasanam), 
 Savaasanam, 
            Poorana shanthi asanam, 
NAME OF   PRANAYAMAM: 
 Omkhara  Pranayamam 
 Nithirai Pranayamam  
 
Day Date Morning Evening Day Date Morning Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23    Day47    
Day24    Day48    
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
 
 
 
 
 
            
              NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE- CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI KARAPPAN”(ECZEMA). 
FORM IV D - DIETARY ADVICE FORM 
§º÷ì¸ì ÜÊÂ ¯½×¸û: 
ÓÕí¨¸ôÀ¢ïÍ, (Unripe drumstick), 
«Å¨ÃôÀ¢ïÍ, (Unripe Dolichos bean), 
          ¸Ã¢º¡¨Ä (trailing eclipta), 
¦À¡ýÉ¡í¸ñ½¢ (Sessile plant), 
Á½ò¾ì¸¡Ç¢ (black nightshade), 
ÓÕí¨¸ì¸£¨Ã (Leaves of Drumstick), 
Àº¨Äì ¸£¨Ã(Indian Spinach), 
º¢Ú¸£¨Ã(Tropical Amaranth ), 
¸È¢§ÅôÀ¢¨Ä (Curry leaf), 
¦¸¡ò¾ÁøÄ¢ (Coriander), 
Ò¾¢É¡ (The marsh mint), 
      À¡ø (Milk),  
      À¡ü¦À¡Õð¸û(Milk products). 
 
¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û:       
§¸¡Æ¢ì¸È¢ [Chicken], 
Á£ý[Fish], 
¿ ñÎ [Crab], 
¸ÕÅ¡Î [Dry fish], 
 Óð¨¼ [Egg], 
¦¸¡öÂ¡ [Guava], 
¾ÊÂý¸¡ö [Pumpkin], 
¸õÒ  [Pear millet], 
ÅÃÌ [Kodo millet], 
¾¢¨É [Indian millet], 
º¡¨Á [Little millet], 
ÒÇ¢ôÒ ¦À¡Õû¸û [Sour], 
±ÖÁ¢î¨º [Lemon], 
¾ì¸¡Ç ¢[Tomato], 
¿ø¦Äñ¦½ö [Gingely oil], 
°Ú¸¡ö [Pickle], 
Ò¨¸Â¢¨Ä [Tobacco], 
ÁÐ «ÕóÐ¾ø [Alcohol]. 
 
 
              
 
 
 
 
 
 
 
 
                                          
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON “KUKKILAATHI CHOORANAM” 
(INTERNAL) AND KARAPPAN MEL POOSU THYLAM (EXTERNAL) FOR THE 
TREATMENT OF “VARATCHI KARAPPAN” (ECZEMA). 
 
                                            ADVERSE REACTION FORM 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF OCCURRENCE OF ADVERSE REACTION: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
 
                                               
    
 ¾¸Åø  ÀÊÅõ  
 ¸ÃôÀ¡ý (§¾¡ø §¿¡ö) §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý (Ìì¸¢Ä¡¾¢ ÝÃ½õ 
ÁüÚõ  ¸ÃôÀ¡ý §Áø âÍ ¨¾Äõ)  ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ 
¬öÅ¢üì¸¡Éò  ¾¸Åø  ÀÊÅõ. 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷  : ÁÕòÐÅ÷ .¸. ¸Å¢ÂÃº¢. 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷     :§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, 
                                                  ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ, 
                                                  ¦ºý¨É- 47. 
            §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý 
¸ÃôÀ¡ý ±ýÛõ §¾¡¨Äô À¡¾¢ìÌõ §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø ®ÎÀðÎû§Çý.  
       ¸ÃôÀ¡ý ±ýÛõ §¿¡Â¡ÉÐ §¾¡¨Ä À¡¾¢ìÌõ §¿¡Â¡Ìõ. þó¾ §¿¡Â¢ø 
§¾¡Ä¢ø ¾¢Á¢÷, ÌÕ, Òñ, ¾ÊôÒ ¯¨¼Â À¨¼¸¨Ç ¯ñ¼¡ì¸¢,«ùÅ¢¼í¸Ç¢ø 
Å£ì¸õ,¦¸¡ôÒÇí¸û ¸ñÎ «øÄÐ ¦º¾¢ø §À¡ýÚ §¾¡ø ÍÃÍÃôÀ¡¸¢ §¾¡Ä¢ý 
þÂü¨¸ ¿¢Èò¨¾ §ÅÚÀÎò¾¢, º¢Ä§Å¨Ç ¦ÅÊôÒ, ¿£÷ ¸º¢¾ ø ¯ñ¼¡Ìõ. þÐ 
ÀÃÅì ÜÊÂ §¿¡ö «øÄ. þó¾ ¬Ã¡öîº¢ ºõÁó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç §¸ð¸×õ, 
§¾¨ÅÂ¡É ¬öÅ¸ô ÀÃ¢§º¡¾¨ÉìÌò ¾í¸¨Ç ¯ðÀÎò¾×õ ¯û§Çý. 
       þÐ ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ 
±É ¯Ú¾¢«Ç¢ì¸¢§Èý. þ¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ò ¦¾¡¨¸Ôõ 
ÅÆí¸ôÀ¼ Á¡ð¼¡Ð. þó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ 
Àðºò¾¢ø §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ.  
       þó¾ ¬Ã¡öîº¢ìÌò ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ Àðºò¾¢ø 
¯ûÁÕó¾¡¸ì Ìì¸¢Ä¡¾¢ ÝÃ½õ 1.5¸¢ ¦Åó¿£Ã¢ø 2 §Å¨Ç (¸¡¨Ä, Á¡¨Ä) 
¯½×ìÌô À¢ý 48 ¿¡ð¸ÙìÌ ¯ð¦¸¡ûÇ §ÅñÎõ. ¦ÅÇ¢ ÁÕó¾¡¸ ¸ÃôÀ¡ý 
§Áø âÍ ¨¾Äõ 20 Á¢Ä¢, 48¿¡ð¸ÙìÌ §¿¡ÔûÇ þ¼í¸Ç¢ø ¦ÅÇ¢§Â ¾¼Å 
§ÅñÎõ.¦ÅÇ¢ §¿¡Â¡Ç÷¸û 7 ¿¡ð¸ÙìÌ ´ÕÓ¨È ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ. 
¯û§¿¡Â¡Ç¢Â¡¸ò ¾í¸ Å¢ÕôÀõ ¦¾Ã¢Å¢ìÌõ Àðºò¾¢ø §¿¡öìÌò ¾Ìó¾    
À¢Ã¡½¡Â¡Áõ ÁüÚõ §Â¡¸¡ºÉô ÀÂ¢üº¢¸û ¸üÚò ¾ÃôÀÎõ. 
      þó¾ ¬Ã¡öîº¢Â¢ø §¿¡Â¢ÉÃ¡¸î §º÷ó¾ À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ 
þø¨Ä¦ÂÉ¢ø ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ì ¦¸¡ûÇ ÓØ ¯Ã¢¨Á ¯ûÇÐ.  
þó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ, §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ Ó¾ý¨Á 
¬Ã¡öîº¢Â¡ÇÃ¡É Dr.¸.¸Å¢ÂÃº¢ (Àð¼ §ÁüÀÊôÀ¡Ç÷- º¢ÈôÒ ÁÕòÐÅô À¢Ã¢×) ¨Â 
«Ï¸×õ. ¨¸ô§Àº¢ ±ñ 9677360596.§ÁÖõ þó¾ ¬Ã¡öîº¢ìÌò ¾ì¸ «ÛÁ¾¢ 
[IEC]º¡ýÚ ¦ÀÈôÀðÎûÇÐ. 
þó¾ ÁÕóÐ º¢ÈôÀ¡¸ì ¸ÃôÀ¡ý §¿¡öì¸¡¸ (§¾¡ø §¿¡ö)«í¸£¸Ã¢ì¸ôÀð¼ 
º¢ò¾ ÁÕòÐÅ áÄ¢ø ÜÈôÀðÎûÇÐ. ²ü¸É§Å ¯À§Â¡¸ò¾¢ø ¯ûÇ þÐ §À¡ýÈ 
ÁÕóÐ þÐÅ¨Ã §¿¡Â¡Ç¢¸Ç¢¼õ ±ó¾ Å¢¾ Àì¸ Å¢¨Ç×¸¨ÇÔõ ²üÀÎò¾Å¢ø¨Ä. 
þó¾ ÁÕóÐ ÓüÈ¢Öõ ãÄ¢¨¸¸¨Çì ¦¸¡ñÎ ¾Â¡Ã¢ì¸ôÀð¼ À¡Ð¸¡ôÀ¡É 
ÁÕó¾¡Ìõ. 
 
 
 
